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Abstract (English) 
Background. Long noncoding RNAs (lncRNAs) form an abundant class of 
transcripts that is acquiring an increasing importance due to the roles that some of 
these molecules have been demonstrated to exert in various biological processes. 
Unfortunately, the function of the majority of them remains elusive. LncRNA are 
involved in different epigenetic mechanisms of gene regulation, from chromatin 
remodelling to post-transcriptional regulation. Since their function is related to 
their subcellular localization and expression, a genome-wide approach to 
determine the localization of lncRNAs could greatly improve our understanding 
of their role in pathophysiology of skeletal muscle. 
Results. To investigate the subcellular localization of lncRNAs expressed in 
single skeletal muscle fibers, we studied their compartmentalization by coupling 
microarray technique with differential extraction and analysis of nuclear and 
cytoplasmic RNA. We found that 481 lncRNAs preferentially localize in the 
nucleus, 655 in the cytoplasm and 297 show an alternate localization depending 
on muscle type and/or lncRNA isoform. Microarray based lncRNA subcellular 
localization was validated by Fluorescent In Situ Hybridization (FISH) on 6 
lncRNAs. All FISH tests confirmed the subcellular localization previously 
evidenced by the microarray approach. We then chose 32 lncRNAs to investigate 
their expression profile among different tissues. Of this group, 24 appear to be 
preferentially expressed in skeletal muscle, 5 in the heart, and only 2 have a high 
expression in the liver. Skeletal muscle can be approximately classified according 
contractile capacity as fast and slow, reflecting fiber composition and metabolism. 
For this reason, we tested the group of 32 lncRNAs for expression in fast or slow 
myofibers using single-cell analysis, evidencing that 9 lncRNAs have a specific 
fiber expression probably affecting metabolic traits. To identify lncRNAs 
involved in skeletal muscle atrophy we also investigated their expression in 
skeletal muscle during denervation and starvation as well as in a mouse model for 
Amyotrophic Lateral Sclerosis. We then analysed the expression of the same 
lncRNAs in proliferating and differentiating C2C12 myoblasts both in purified 
myonuclei and cytoplasm. 20 lncRNAs presented with differential expression 
during myogenic differentiation. 
Conclusions. We localized several lncRNAs inside the skeletal muscle 
evidencing their preferential expression in this tissue and also in specific 
myofibers. Moreover, we evidenced that many lncRNAs expressed in the muscle 
are involved in skeletal muscle atrophy induced by different models and in its 
differentiation. Finally, we evidenced that lncRNA Pvt1 is able to shuttle between 
cytoplasm and nucleus during myoblast differentiation in-vitro. 
  
VI 
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Abstract (Italiano) 
Background. La classe di trascritti composta dai long non coding RNA (lncRNA) 
sta acquisendo una crescente importanza a causa dei molteplici ruoli che alcune di 
queste molecole hanno dimostrato di avere in vari processi biologici. 
Sfortunatamente, la funzione della maggior parte di questi RNA rimane al 
momento sconosciuta. I lncRNA sono coinvolti in diversi meccanismi epigenetici 
di regolazione genica, dal rimodellamento della cromatina alla regolazione post-
trascrizionale. Dal momento che la loro funzione è legata alla loro espressione e 
localizzazione subcellulare, usare un approccio genome-wide per determinare la 
localizzazione di lncRNA potrebbe migliorare notevolmente la nostra 
comprensione del loro ruolo nella fisiopatologia del muscolo scheletrico. 
Risultati. Per studiare la localizzazione subcellulare dei lncRNA in singole fibre 
del muscolo scheletrico abbiamo estratto RNA nucleare e citoplasmatico per 
analizzarlo mediante la tecnica microarray. Abbiamo identificato 481 lncRNA che 
localizzano preferenzialmente nel nucleo, 655 nel citoplasma e 297 che 
localizzano in diversi compartimenti a seconda dell’isoforma scelta o del tipo di 
muscolo analizzato. La localizzazione subcellulare identificata via microarray è 
stata validata, per 6 lncRNA, mediante Fluorescent In Situ Hybridization (FISH). 
Questi esperimenti hanno confermato la localizzazione subcellulare 
precedentemente identificata con l’analisi microarray. Successivamente abbiamo 
scelto 32 lncRNA di cui abbiamo studiato il profilo di espressione in diversi 
tessuti. Di questo gruppo, 24 risultano essere espressi preferenzialmente nel 
muscolo scheletrico, 5 nel cuore, e 2 nel fegato. Il muscolo scheletrico può essere 
caratterizzato come veloce o lento a seconda della velocità di contrazione, questa 
caratteristica è dovuta alla presenza di fibre muscolari che sfruttano un 
metabolismo ossidativo (contrazione lenta) o glicolitico (contrazione veloce). Per 
questo motivo, abbiamo analizzato l’espressione degli stessi 32 lncRNA in singole 
miofibre veloci e lente. Grazie a questa analisi abbiamo evidenziato 9 lncRNA che 
hanno un’espressione fibra-specifica e sono possibilmente legati al metabolismo. 
Per identificare lncRNA coinvolti nell’atrofia del muscolo scheletrico abbiamo 
studiato la loro espressione nel durante denervazione e denutrizione. In aggiunta 
abbiamo analizzato la loro espressione in un modello murino di sclerosi laterale 
amiotrofica (ALS). Abbiamo poi analizzato l'espressione degli stessi lncRNA in 
colture di mioblasti C2C12, in RNA estratto differenzialmente da nucleo e 
citoplasma. Abbiamo individuato 20 lncRNA differenzialmente espressi durante il 
differenziamento miogenico. 
Conclusioni. Abbiamo individuato la localizzazione subcellulare di diversi 
lncRNA nel muscolo scheletrico, evidenziando la loro espressione preferenziale in 
questo tessuto e individuando in che tipo di fibra sono più espressi. Inoltre, 
abbiamo evidenziato che l’espressione di molti lncRNA muscolari è alterata 
durante il differenziamento dei mioblasti e durante l’atrofia indotta da diversi 
modelli. Infine, abbiamo evidenziato che la localizzazione del lncRNA Pvt1 
cambia da citoplasma a nucleo durante il differenziamento dei mioblasti in vitro. 
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Chapter 1 – Introduction 
 
1.1 Long non-coding RNAs (LncRNAs) 
Large-scale sequencing projects and genomic tilling arrays have provided 
new unexpected and intriguing information about the organization and function of 
the mammalian genomes. Transcription in mammals is pervasive throughout the 
genome and not limited to protein-coding regions, giving rise to a complex 
network of transcripts, most of which have little or no coding capacity. This class 
of transcripts is referred to as non-coding RNAs (ncRNAs)
1
. 
The organism complexity among species better correlates with the portion of 
genome that is transcribed into non-coding RNAs than with the number of 
protein-coding genes, even when diversification by both alternative splicing and 
post-translational regulation are taken into account. This suggests that RNA-based 
regulatory mechanisms played a relevant role in the evolution of the complex 
developmental mechanisms in eukaryotes, highlighting the importance of RNA-
based control in the evolution of multicellular organisms
2
. RNA is in fact, a 
preferred substrate for epigenetic dynamics because it can rapidly shift between 
multiple stable conformations and undergo allosteric transitions, acting as a 
responsive switch
3
. 
Non-coding RNAs below 200 bp are defined Small ncRNA and include transfer 
RNA (tRNA), ribosomal RNA (rRNA), small nuclear RNAs (snRNA), small 
nucleolar RNAs (snoRNA), microRNAs (miRNAs), small interfering RNAs 
(siRNAs) and Piwi-interacting RNAs (piRNAs). 
Non-coding transcripts longer than 200 bp are instead defined as long non coding 
RNAs
4
. 
Transcriptional regulation of loci includes both coding and non-coding transcripts 
with lncRNAs representing a sizable expansion of the transcriptome. It is difficult 
to gauge an exact number of lncRNAs. However, whereas the number of known 
protein-coding genes has remained stable over recent years, the number of known 
lncRNAs continues to increase.As a result of these studies, lncRNAs are being 
increasingly accepted as a new gene class
3
. 
Taken together, these findings suggest that non protein-coding sequences house a 
set of information-rich instructions, many of which are likely to be regulatory in 
nature and have contributed to the increase of biological complexity
5
. 
2 
1.1.1 Evolution of a non-coding world 
Most non-coding RNA genes are subjected to a low degree of evolutionary 
constraints and are thus diverging rapidly. It is therefore difficult to depict the 
evolutionary scenario that led to the emergence of a functional non-coding gene. 
Different hypothesis can explain the underlying mechanisms. 
The first scenario is the emergence of a non-coding RNA gene from a protein-
coding gene. This conversion involves the loss of protein-coding capacity and the 
acquisition of a newly function associated with the presence of the RNA in the 
cell. This scenario is possible taken into account the great number of pseudogenes 
present in eukaryotic genomes. Many of them can be transcribed and play 
functional roles. 
Another possibility is the emergence of non-coding RNAs following the insertion 
of transposable elements
1
. The tissue specificity of long non-coding RNAs has 
been attributed to the presence of transposable elements that are embedded in the 
vicinity of lncRNA transcription start sites. This relevance is supported by the 
discovery that, in vertebrates, transposable elements are found in more than two-
thirds of mature lncRNAs, whereas they are rarely found in protein-coding 
transcripts
2
. 
A third mechanism is represented by the de novo emergence of non-coding RNA 
genes, for example, from the transcriptional activation of a large intergenic region 
containing pre-existing cryptic splice sites
1
. 
As a final hypothesis, the evolution of non-coding genes could result from a 
combination of different mechanisms, as illustrated by the evolutionary history of 
the X-inactivation center
5
. 
 
1.1.2 Long non-coding RNAs at every stage of gene expression 
The role of lncRNAs in genomic imprinting is the most characterized. 
Genomic imprinting in mammals results in a monoallelic expression pattern of a 
subset of genes due to the parental origin. Most of these genes are located in 
clusters that are regulated through long non-coding RNAs (a well-known example 
is H19/Igf2). Imprinted gene expression is conferred through lncRNAs. This is 
supported by the evidence that the majority of imprinted clusters contain at least 
one lncRNA
6
. 
LncRNAs have emerged as key regulators of gene expression at multiple levels 
controlling different aspects of cell fate
4
. Moreover, lncRNAs are involved in 
stem cell maintenance, environment-responsive programs
2
, and also contribute to 
3 
disease
4
. LncRNAs are novel “fine tuners” of gene regulation2: their expression 
pattern is developmental stage- and cell type- dependent
4
 and their spatial-
temporal expression is specific across various stages of differentiation
2
. 
Moreover, lncRNAs help to orchestrate the epigenetic transcriptional state
7
 at 
almost every stage of gene expression
3
. These findings reinforce their biological 
role and highlight them as central regulators in a very plastic tissue such as 
skeletal muscle that undergoes continuous adaptive responses. 
 
1.1.3 Biogenesis of long non-coding RNAs 
Derrien and colleagues compared lncRNAs features to those of protein-
coding
8
 RNAs, to evidence similarities and discrepancies with most known 
coding genes. 
They evidenced that lncRNAs are expressed at lower level than protein-coding 
transcripts and their pattern of expression is more developmental stage and cell 
type specific
4
. 
Analyses on lncRNAs maturation indicate that they are generated through 
pathways similar to that of protein-coding genes, but as independent 
transcriptional units, even if lncRNAs loci are often in close association with 
protein coding genes. LncRNAs are defined as transcript with little or no coding 
capacity (Figure 1) and some lncRNAs are preferentially processed into small 
RNAs such as miRNAs or snoRNAs
8
. It was evidenced that small polypeptides 
(micropeptides) can origin from lncRNAs impacting on muscle performance
9
. 
Therefore, a more reasonable approach may be to use a definition of non-coding 
that focuses on a coding-independent functional role of the RNA transcript; a 
lncRNA must function as a RNA transcript, whether or not it may also code for 
polypeptide
10
. For example, it could maintain the ability of coding micropeptides 
in some circumstances and in other to function as decoy for miRNAs or interact 
with other proteins. 
 
Figure 1. Most lncRNAs lack any protein-
coding potential. 
To test whether lncRNAs are able to code for a 
protein and to find the longest ORF in lncRNAs 
it was used GeneID algorithm. Results were 
compared with known protein-coding transcripts 
(red), experimentally validated lncRNAs such as 
XIST and H19 (blue), and a set of ‘‘decoy’’ 
lncRNAs (purple), obtained by mapping lncRNA 
gene structures randomly onto the genome. 
LncRNAs have no coding potential. Image 
modified from Derrien et al.
8
. 
4 
Most lncRNAs are transcribed by RNA polymerase II and many share mRNA-
like features such as 5’cap, poly-A tail and splicing sites; alternatively, non-
polyadenylated lncRNAs are likely generated by RNA polymerase III
4
. 
In GENCODE database
11
, that gets information from the ENCODE project
12
 and 
ENSEMBL database
13
, an unusual exonic structure is described for lncRNAs. A 
lot of lncRNAs are spliced (98%) using similar splicing signals used for coding 
transcripts, but lncRNAs show a striking tendency to have only few exons. 
Even if lncRNA exons are slightly longer than those of protein-coding RNAs, 
overall lncRNA transcripts are shorter than protein-coding because there are a 
minor number of exons. 
Analyses for histone methylation and acetylation patterns around TSSs 
(transcription start sites) of lncRNAs and coding transcripts show that histone 
profiles are similar for several active histone marks (H3K4me2, H3K4me3, 
H3K9ac, H3K27ac), but have slightly excess levels of other marks associated 
with both chromatin silencing (H3K27me3) and activation (H3K36me3) in TSSs 
of lncRNA. This information is important because histone modifications are key 
players in the regulation of gene expression. 
 
1.1.4 LncRNA structure and biochemistry 
A peculiar feature of lncRNAs is the propensity to fold into 
thermodynamically stable secondary and high-ordered structures. RNA has then 
the capacity to form double helices, hairpin loops, bulges and pseudoknots that are 
connected in high order tertiary interactions primarily mediated by non-canonical 
Watson-Crick base-pairing
3
. RNAs have flexible and modular scaffold nature that 
creates a complex structural landscape in lncRNAs and, in many cases, the 
secondary structures dictate their function because of the presence of functional 
domains. 
The secondary structures generally fold initially and independently, before 
subsequent tertiary interactions occur, resulting in the hierarchical assembly of 
RNA structure. It is important to understand the biochemical features of RNA 
from which secondary structures derive
3
. 
As shown in Figure 2, four functional domains can be present in lncRNAs: 
1.  RNA binding domains. Thanks to the ability of pairing with other RNAs, 
lncRNAs can act as highly specific sensors of mRNAs, miRNAs and other 
lncRNAs. Small and often imperfect regions of nucleotide complementarity 
5 
are sufficient for specific interactions. This imperfect complementarity has 
the advantage of allowing multiple RNA agonists to compete for binding, 
allowing lncRNAs to sense different RNA expression signals in the cells. 
 
2.  Protein binding domains. Proteins are the major partners of lncRNAs, with 
complexed ribonucleoprotein (RNP) particles acting as chaperones, transport 
aids or effectors. Proteins-RNA interactions tend to result in conformational 
changes of protein structure, RNA structure or both. The structural variety of 
RNA in combination with the abundance of RNA-binding proteins provides a 
broad interface for communication between the proteome and the 
transcriptome. 
 
3. DNA binding domains. There are few evidences for direct interaction between 
lncRNAs and DNA. RNA-DNA hybrids or triplex structure can allow single 
strands of RNA to interact with DNA duplexes by base-pair interactions. 
These direct RNA-DNA interactions could efficiently and selectively target 
RNA signals to genomic loci. Rather than being involved in direct 
complementarity, RNA folds may create a DNA binding pocket as a protein 
transcription factor or facilitate protein localization in specific genomic 
domains. An example of this property is the CRISPR RNA (which can recruit 
Cas9 endonuclease to target specific sequence in the genome. 
 
4.  Conformational switch. LncRNAs can act as regulatory devices by 
allosterically coupling binding domains and thereby activate or suppress 
linked functional domains. Examples of these functional domains can be A- 
and C-repeats deriving from the insertion and remodeling of repetitive 
elements. 
 
 
Figure 2. Domain architecture of lncRNAs. 
LncRNAs contain structural domains that can sense or bind a) other RNAs via complementary 
base pair interactions, b) proteins and c) DNA that can induce d) allosteric conformational 
changes to other structures in the lncRNA. Image modified from Mercer et al.
3
. 
6 
1.1.5 Classification of lncRNAs 
As seen before, non protein-coding RNAs (ncRNAs) are divided into small 
and long non-coding. LncRNAs can be further classified based on their genomic 
localization with respect to protein-coding genes in genic and intergenic 
lncRNAs
8,14
: 
 
 Genic lncRNAs, are divided in 
a) Exonic lncRNAs: lncRNAs that overlap exonic regions of a  
protein-coding gene; 
b) Intronic lncRNAs: lncRNAs that overlap intronic regions of a  
protein-coding gene, but do not intersect any exons; 
c) Overlapping lncRNAs: lncRNAs that overlap a protein-coding gene  
in the sense or antisense direction. 
 
 Intergenic lncRNAs (lincRNAs) are lncRNAs located between annotated 
protein-coding genes, generally in their close proximity, but do not overlap 
in any way with annotated transcriptional units. 
 
Figure 3 shows how the GENCODE consortium has defined different classes of 
lncRNAs. 
 
 
 
 
Figure 3. Classification of lncRNAs. 
Classification of lncRNAs based on 
intersection with protein-coding genes by 
GENCODE consortium. Image modified 
from Derrien et al.
8
. 
7 
LncRNAs can epigenetically regulate gene expression by recruiting specific 
methylases or demethylases, acethylases or deacethylases to chromatin. For this 
reason, it would be expected that lncRNAs should be preferentially localized in 
the nucleus, in contrast to protein-coding mRNAs that are trafficked to the 
cytoplasm for translation
8
. This is not always true, since a substantial portion of 
lncRNAs reside within, or are dynamically shuttled to the cytoplasm, where they 
regulate protein localization, mRNA translation and stability
3
. Based on their site 
of action, lncRNAs can be also divided into two functional categories: nuclear 
and cytoplasmic lncRNAs
4
. 
Nuclear lncRNAs have their site of action in the nucleus. They can be further 
subdivided in: a) cis-acting RNAs and b) trans-acting RNAs with respect to the 
target site. 
Cis-acting RNAs work in proximity to their site of transcription and can 
sometimes spread their effect to long distances on the same chromosome
2,4
 
(Figure 4). 
Trans-acting RNAs, instead, operate at distant loci
2,4
 (Figure 4). 
Both can activate or repress transcription, but the targeting mechanism is still far 
from being understood. Different hypothesis can explain lncRNA roles in the 
nucleus. 
A lncRNA can recognize its target directly, a) by the recruitment of bridging 
proteins, b) by the formation of an RNA-DNA triplex or c) through DNA 
recognition by RNA structures
2
. Alternatively a lncRNA indirectly can, a) act as a 
decoy to sequester transcription factors, b) allosterically modulate regulatory 
proteins, or c) alter nuclear domains and long-range three-dimensional 
chromosome structure
2
. 
LncRNAs can also guide chromatin remodels and modifiers to specific genomic 
loci. For example, the formation of heterochromatin to induce transcriptional 
repression occurs with the recruitment of DNA methyltransferase 3 (DNM3) and 
Histone H3 lysine 9 (H3K9) methyltransferases. Transcription activation indeed 
occurs by activation of MILL1 complex (a multiprotein complex that mediates 
both histone H3 trimethylation at lysine 4 (H3K4me3) and histone H4 acetylation 
at lysine 16 (H4K16ac) and by activation of specific enhancer regions through 
changes in the three-dimensional chromatin conformation
2
. 
It is known that lncRNAs are able to recruit or prevent the binding of 
transcriptional machinery and transcription factors, thus modifying gene 
transcription. An example is represented by enhancer RNAs (eRNAs), encoded by 
extragenic enhancer regions that promote transcription of surrounding genes. 
8 
LncRNAs also participate in co- and post-transcriptional regulation: they can 
interact with the splicing machinery or directly with a nascent mRNA to guide 
particular splicing events. 
Finally, lncRNAs can shape the subnuclear architecture in different ways: a) 
regulating chromosome looping, favoring or disrupting chromosomal interactions 
and b) acting as structural scaffold for the formation and regulation of nuclear 
compartments such as speckles, paraspeckles and Polycomb bodies
4
. 
 
 
 
 
Figure 4. Mechanisms of 
action of lncRNAs that 
guides chromatin 
modifying complexes. 
On the left, a cis-acting 
lncRNA, on the right, a 
trans-acting lncRNA. Image 
modified from Fatica et al.
2
. 
 
Cytoplasmic lncRNAs have their site of action in the cytoplasm. LncRNAs that 
work in this compartment, recognize their target by base pairing thanks to 
sequence complementarity
2
. Cytoplasmic lncRNAs influence translational output 
in two main ways. Firstly, they can modulate the translational rate by regulating 
polysome loading to an mRNA molecule or through the control of internal 
ribosomal entry sites (IRES); secondly, they can regulate gene expression by 
reducing or stimulating mRNA decay
4
. An example of the first case, is the rapid 
response to environmental changes, mediated by UCHL1 expression without de 
novo RNA synthesis. 
The expression of UCHL1 protein cannot take place by its normal cap-dependent 
manner because of stress-induced inhibition of mTOR activity. In this case, the 
lncRNA Uchl1-as1 (antisense transcript to the neuron specific Uchl1 gene) is 
exported in the cytoplasm. 
Through a base pairing with the Uchl1, Uchl1-as1 stimulates Uchl1 cap-
independent translation thanks to an inverted SINEB2 element in Uchl1-as1 
(Figure 5)
2
. 
9 
 
Figure 5. Uchl1/antisense (AS) Uchl1 genomic organization and mechanism of action. 
a. Uchl1 exons are in black; 3’ and 5’ UTRs are in white; antisense Uchl1 exons are grey; 
repetitive elements are in red (Alu) and blue (SINEB2). Introns are indicated as lines. b. The 
interaction between protein coding RNA and antisense non-coding RNA presenting an inverted 
SINEB2 element allows the translation of protein coding, augmenting the protein content without 
affecting mRNA abundance. Image modified from Carrieri et al.
15
. 
An example of mRNA decay influenced by lncRNAs is represented by Staufen-
mediated mRNA dacay (SMD). When a SINE element in 3’ UTR of a protein-
coding RNA forms intermolecular base pairing with a partially complementary 
SINE of one or more lncRNAs, the resulting double-stranded RNA can be 
recognized by Staufen 1 and Staufen 2 and degraded through SMD (Figure 6). 
Another interesting mechanism of action is the hybridization to miRNAs. Thus 
lncRNAs can act as competing endogenous RNAs (ceRNA). Since they can act as 
molecular sponges for miRNAs, they are able to modulate the repressive activity 
of miRNA on their mRNA targets
4
 creating a regulatory circuit where coding and 
non-coding RNAs cross-talk to each other (Figure 6)
2
. 
 
 
Figure 6. Staufen mediated decay (SMD) and action of competing endogenous RNAs 
(ceRNAs). 
a. SMD is induced when intermolecular base pairing is formed between an Alu element (or short 
interspersed element (SINE) in mice) in the 3′ UTR of the mRNA and an Alu/SINE element 
within a long half-STAU1-binding site RNA (1/2sbsRNA). This mRNA decay mechanism also 
involves the RNA helicase up-frameshift 1 (UPF1). b. By contrast, STAU1-mediated mRNA 
stabilization has been described in the case of tissue differentiation-inducing non-protein coding 
RNA (TINCR). c. Antisense recognition has been shown to also control translation. LncRNAs can 
act as miRNA sponges, thus favouring the expression of the mRNAs targeted by the sequestered 
miRNA. As lncRNA also circular RNAs (circRNAs) can function as miRNA sponges. Image 
modified from Fatica et al.2. 
a.                                                                b. 
10 
1.2 Muscular system 
The muscular system is not only devoted to support, protect and move the 
body, but it also has an important role in body metabolismwith its capacity of 
adapting to different conditions like changes in mechanical demands, or food 
intake.  
 
1.2.1 Three main types of muscles 
Muscle cells differentiate along one of three main pathways to form skeletal, 
cardiac or smooth muscles. 
Skeletal muscle forms the bulk of the muscular tissue of the body and consists of 
parallel bundles of long, multinucleated fibers. It is capable of powerful 
contraction because of the regular organization of contractile proteins that occupy 
the cytoplasm of muscle cells. Skeletal muscle is referred to as voluntary muscle, 
because their contraction is often initiated under conscious control. However this 
is a misleading term: skeletal muscle is involved in many movements, such as 
breathing, mainly or exclusively driven at an unconscious level. 
Cardiac muscle is found only in the heart and in the walls of large veins where 
they enter the heart. It consists of a branching network of individual cells that are 
linked electrically and mechanically to function as a unit. It is much less powerful 
but more resistant to fatigue compared to skeletal muscle. Cardiac muscle differs 
structurally and functionally from skeletal muscle: it is intrinsically capable of 
rhythmic contraction, with a rate and strength that are responsive to hormonal and 
autonomic nervous control. 
Smooth muscle is found in many different systems of the body: gastrointestinal, 
respiratory, urinary, reproductive tracts, and in the dermis. The elongated cells are 
tapered at the ends and are smaller than those of striated muscle. They are capable 
of slow but sustained contractions and, although the contraction is less powerful, 
the amount of shortening can be much greater. Smooth muscle is involved in the 
regulation of the size of lumen and the consequent movement of the luminal 
content. This type of muscles is excited by autonomic nerve fibers, or a blood-
borne neuro-hormone; none is under conscious control, and for this reason it is 
referred as involuntary muscle. 
Both skeletal and cardiac muscles may be called striated muscles, because myosin 
and actin filaments are organized into regular, repeating elements (the sarcomeres) 
which give to the cells a finely cross-striated appearance when observed at the 
microscope. Smooth muscle, in contrast, lacks such repeating elements and thus 
present no striations. 
11 
1.2.2 Skeletal muscle 
Skeletal muscles are composed by an heterogeneous collection of cell types: 
myofibers, fibroblasts, endothelia cells, blood cells, nerves and many other. All 
together these different cells allow for the wide variety of capabilities that skeletal 
muscles of different body districts display
16
. 
 
1.2.2.1 Anatomy of skeletal muscle 
1.2.2.1.1 Macroscopic Structure 
Cellular units of skeletal muscle are enormous, multinucleated muscle fibers, 
that are cylindrical structures ranging from 10 to 100 µm in diameter and from 
millimeters to many centimeters in length. Along an entire fiber, nuclei can be 
several hundred. The cytoplasm of each fiber, the sarcoplasm, is surrounded by a 
plasma membrane called sarcolemma. Between the sarcolemma and the 
surrounding basal lamina, myogenic satellite cells (muscle stem cells) reside. 
Each fiber consists in an ensemble of myofibrils, long narrow structure (1-2 µm in 
diameter) forming the bulk of the sarcoplasm; myofibrils develop in turn by the 
fusion of individual myoblasts. When a lot of muscle fibers join together they 
form a single fascicle, and the union of multiple fascicles forms a muscle (Figure 
7). 
 
 
Figure 7. Organizational levels of skeletal 
muscle. 
Different levels of organization in skeletal 
muscle are represented. From inside to out: 
muscle fiber, fasciculo, entire muscle. For 
each level is also shown the respective 
sheaths of connective tissue that surround it: 
endomysium, perimysium, epimysium. 
Image from
17
. 
Epimysium, perimysium and endomysium (Figure 7) are sheaths of connective 
tissue prevalently made of collagen that respectively surround an entire muscle, a 
single fascicle, and a single fiber. They also connect muscle to adjacent structures 
such as tendons. In particular, endomysium is a delicate network of connective 
tissue that forms the immediate external environment of a muscle fiber. It is the 
site of metabolic exchange between muscle and blood, and contains capillaries 
and bundles of small nerve fibers. 
12 
1.2.2.1.2 Microscopic Structure 
Skeletal muscle, as stated before, is a striated muscle because of its protein 
organization. Z-discs (Zwischenscheiben discs), streaks of proteins, divide the 
myofibril into a linear series of repeating contractile units, the sarcomeres, each of 
which is typically 2.2 µm long in resting muscle. Sarcomeres consist of two types 
of filaments, thick and thin, organized into regular arrays. Thick filaments are 
composed of myosin while thin filaments are mainly composed of actin. The array 
of thick and thin filaments form a partially overlapping structure that under an 
electron microscope appears as a pattern of alternate dark and light bands: the 
banded appearance of individual myofibrils is a function of the regular alternation 
of the thick and thin filament array as shown in Figure 8. The Z-discs are 
contained in the I band (isotropic at the polarized light) made mainly of actin 
filaments. The other band is the dark A band (anisotropic at the polarized light) 
made of both actin and myosin filaments interposed one another. At the center of 
the A band there is a smaller band called H band represented by the myosin 
filaments. The M line, made by proteins that interconnect myosin filaments, is 
present at the center of the H band. 
 
 
 
Figure 8. Protein composition 
of the sarcomere. 
Different bands are present in the 
sarcomere: A-band constituted 
by myosin and actin filaments, 
the I-band constituted by actin 
filaments only and the H-band 
constituted by myosin filaments 
only. The sarcomere is delimited 
by Z-discs at both ends. Image 
modified from
17
. 
 
1.2.2.1.3 Proteins and supporting structures 
As already discussed, sarcomeres consist of two types of filaments, thick and 
thin: the interaction of these elements allows muscles to contract
16
. The myosin 
protein in the thick filaments constitutes 60% of the total myofibrillar protein 
content. This protein is composed of six polypeptides: two heavy and four light 
chains. The heavy chains contain the myosin heads that interact with actin and 
allow muscle to contract. The myosin heavy chain also contains the ATP binding 
sites: they provide energy for muscle contraction
16
. Other regulatory proteins of 
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myosin are the tropomyosin and the troponin proteins that play an important role 
in the control of contraction. Actin is the next most abundant contractile protein 
and constitutes 20% of the total myofibrillar proteins. In its filamentous form F-
actin is the principal protein of the thin filaments. A number of proteins which are 
neither contractile nor regulatory are responsible for the structural integrity of the 
myofibrils, and for this reason, for fibers contraction capacity. Another important 
protein found in the muscle is dystrofin, it binds to actin intracellularly and is also 
associated with a large oligomeric complex of glycoproteins, the 
dystroglycan/sarcoglycan complex that stabilizes the muscle fiber and transmits 
forces to the extracellular matrix. 
Dystrophin gene is affected in Duchenne muscular dystrophy (DMD), a fatal 
disorder that develops from the absence of this protein. The gene is one of the 
largest encoded and accounts for the high mutation rate of DMD (35% of cases 
are new mutations). 
Essential for muscle fiber functions are organelles such as ribosomes, Golgi 
apparatus and mitochondria. Most of them are located around the nuclei, between 
myofibrils and sarcolemma. Mitochondria, lipid droplets and glycogen provide 
the metabolic support needed by active muscle. The number of mitochondria in an 
adult muscle fiber is not fixed, but can increase or decrease quite readily in 
response to sustained changes in muscle activity. Lipid droplets represent a rich 
source of energy that can be used only by the oxidative metabolic pathway in 
fibers that have a high mitochondrial content and good capillary supply. During 
burst of activity, glycogen granules provide an important source of anaerobic 
energy that is independent from blood flow to the muscle fiber. Finally, the 
sarcoplasmic reticulum (SR) is a specialized form of smooth endoplasmic 
reticulum forming cisternae that fills much of the space between myofibrils. In the 
cisternae calcium is stored at a high concentration retained by calsequestrin, and 
can be released during muscle contraction. 
 
1.2.2.1.4 Muscle contraction 
 Voluntary movements mediated by motor neurons determine the activity of 
skeletal muscle. An action potential at the neuromuscular junction causes 
acetylcholine to be released into the synaptic cleft. Acetylcholine triggers an 
instantaneous increase in permeability and conductance of postsynaptic 
membrane. The local depolarization initiates an action potential in the 
surrounding sarcolemma, an excitable membrane in which action potential 
propagates rapidly, ensuring that all parts of the muscle fibers are activated 
rapidly and synchronously. The action potential leads to the release of calcium 
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ions from the sarcoplasmic reticulum that causes an increase of calcium 
concentration in the cytosol. 
Calcium mediates the excitation-contraction coupling thanks to calcium-sensitive 
switches in the thin filaments (troponin-tropomyosin complex). Contraction leads 
to sarcomere shortening, but the length of the thick and thin filaments does not 
change during muscle contraction (Figure 9). The sarcomere shortens thanks to 
the filaments sliding one between the other. Myosin head binds to actin and pulls 
the actin filament along the myosin filament, allowing the sarcomere to shorten 
during contraction (Figure 9). ATP provides energy for the attachment and 
detachment of myosin heads to actin filaments. At the end of excitation, calcium 
is actively transported in the sarcoplasmic reticulum by calcium ATPase pumps, 
and the muscle relaxes. 
 
 
Figure 9. Contraction and 
relaxation of a sarcomere 
during muscle contraction. 
During contraction, the 
sarcomere shortens by the sliding 
of thick and thin filaments one 
another; in relaxation the 
sarcomere revert to initial 
conformation. Image from
18
. 
1.2.2.2 Muscle fibers 
Over the past decades, the number of techniques available for classifying 
muscle fibers has increased, resulting in several classification systems
16
. The first 
classification of muscles was based on the colour of muscles themselves. The 
division into white and red muscle depends on the amounts of myoglobin and on 
the capillary content. This division was also in agreement with the next 
classification of muscles into fast and slow made on the speed of contraction. 
Today, muscle fiber types can be described using three main approaches: 1) the 
histochemical staining for myosin ATPase, 2) the identification of myosin heavy 
chain isoforms and 3) the metabolic assay. 
1. Histochemical staining for myosin ATPase. During the cross-bridge cycle, the 
myosin molecule hydrolyses ATP for force generation therefore measures of 
ATPase activity can be interpreted in terms of contraction speed. Using the 
myosin ATPase staining two main categories can be described: (a) type I 
fibers, slow contracting, and (b) type II, fast contracting. 
15 
2. Myosin heavy chain isoforms identification. Identification of different myosin 
heavy chain isoforms (MCH) allows for fiber type classification. The single-
fiber electrophoretic separation (SDS-PAGE technique) is used to identify the 
pattern of myosin heavy chain isoforms expressed in a given muscle. Although 
the human genome contains at least ten genes for myosin heavy chains, only 
three are expressed in the adult. From the slowest to fastest, these isoforms are 
MCHI, MCHIIa and MCHIIx. A further fast isoform is present in mice: the 
MCHIIb. 
3. Metabolic assay. On the basis of metabolic differences, individual fibers can be 
classified as predominantly oxidative (slow-twitching “red” fibers), or 
glycolitic (fast-twitching “white” fibers). Oxidative/aerobic fibers obtain their 
energy by aerobic oxidation of substrates, particularly of fats and fatty acids. 
They have large numbers of mitochondria, contain myoglobin and are 
supported by a well-developed network of capillaries. At the other end of the 
spectrum, glycolitic/anaerobic fibers have few mitochondria, little myoglobin 
content, and sparse capillary network, these fibers store energy as cytoplasmic 
glycogen granules. Their immediate energy requirements are met through 
anaerobic glycolysis: they are capable of brief burst of intense activity but less 
sustainable than oxidative metabolism. 
 
This classification leads to three fiber types: fast-glycolytic (FG), fast-oxidative 
(FOG), and slow oxidative (SO) (Table 1). 
Type I fibers are generally oxidative (slow oxidative) and resistant to fatigue, type 
IIA are moderately oxidative (fast oxidative) and fatigue resistant, type IIB largely 
rely on glycolytic metabolism (fast glycolytic) and are easily fatigued. In mouse, 
type IIX fibers have an intermediate phenotype (oxidative/glycolic), but they are 
usually described as fast fibers. 
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Table 1. Skeletal muscle fiber types. 
Muscles contain fibers of different types; in general more than one myosin isoform is expressed in 
a single fiber, a condition far from the simple pure fiber type. The IIX isoform is expressed only in 
mouse, even though the gene is also found in the human genome. 
Fiber Type Myosin gene Myosin Protein Contractile speed Metabolism 
I MYH7 MyHC-I Slow Oxidative 
IIA MYH2 MyHC-IIA Fast Oxidative 
IIX MYH1 MyHC-IIX Fast Oxidative/Glycolitic 
IIB MYH4 MyHC-IIB Fast Glycolitic 
 
 
Not only structural protein expression and metabolism can be used to classify 
muscle fibers but also the association with motor neurons. Based on the 
contractile and fatigue characteristics of the muscle fibers, motor units are first 
classified as slow-twitching (S) or fast-twitching (F), and then as fast-twitching 
fatigue-resistant (FR), fast-twitching fatigue-intermediate (Fint), and fast-
twitching fatigable (FF)
16
. 
 
1.2.2.2.1 Fiber type transformation 
 Fiber composition of a muscle is determined in part by genetic factors. 
However, myofibers are not fixed units but instead are capable of changing their 
phenotype profile in terms of both size and type
16
. This is associated with muscle 
plasticity. If fast muscles are stimulated with an electrical pattern similar to that 
normally experienced by slow muscles (several weeks at 10Hz), they develop 
slow contractile characteristics and acquire a red appearance with a resistance to 
fatigue even greater than that of slow muscles. If this stimulation is removed, the 
sequence of events is reversed and the muscle regains, over a period of weeks, the 
original characteristics. This plasticity in contractile and metabolic properties 
occurs in response to demand, muscle diseases and endurance exercise. The 
muscle undergoes changes in a) the metabolic pathways responsible for the 
generation of ATP and, b) in the dependence on anaerobic/aerobic metabolism
19
. 
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1.2.2.2.2 Muscle classification 
When a certain type of fiber prevails, the muscle in its totality shows 
characteristics that reflect that type of fiber. 
In literature a lot of articles examine the fiber composition of the leg muscles such 
as soleus, extensor digitorum longus (EDL), tibialis anterior (TA), and 
gastrocnemius
20
. The soleus is composed mainly by type I fibers, while EDL and 
TA are composed mainly by type II fibers (both IIA and IIB)
20–22
. Therefore, 
soleus is often described as a slow oxidative muscle while EDL and TA as fast 
glycolytic muscle 
Muscle classification according to fiber type composition was important to 
understand if some lncRNAs have a different subcellular location in different 
muscle types (slow/oxidative vs fast/glycolytic). 
 
1.2.2.3 Myogenesis 
Myogenesis is the process by which progenitor cells give rise to myoblasts 
that fuse onto contractile multi-nucleated myofibers. The myogenic gene 
expression program is orchestrated by a hierarchy of transcription factors, 
including the myogenic regulatory factors (MyoD, Myf5, Myogenin, MRF4) and 
the families of myocyte enhancer factor (MEF2A-D) (Figure 10). 
These factors act in coordination with other transcriptional regulators to execute 
the muscle differentiation program
4
. These myogenic transcription factors belong 
to a family called bHLH (basic helix-loop-helix) proteins (sometimes also referred 
to as myogenic regulatory factors, or MRFs). Basic helix-loop-helix proteins bind 
similar sites on the DNA (E-boxes) to activate muscle-specific genes. Any cell 
expressing a myogenic bHLH transcription factor becomes committed to forming 
a muscle cell. The initial cascade starts with the expression of Pax3 that activate 
the MyoD and Myf5 genes. In the formation of skeletal muscles, MyoD establishes 
a temporal cascade of gene activation: it binds directly regulatory regions to 
activate gene expression of muscle specific genes (Mef2), then it activates other 
genes whose products act as cofactors for MyoD, activating a second set of 
muscle-specific genes. MyoD also directly activates its own gene. During 
myogenesis myoblasts align and fuse to form multinucleated myotubes. Muscle 
cell fusion begins when the myoblasts leaves the cell cycle, stop dividing, secrete 
fibronectin onto their extracellular matrix and bind to it by integrin proteins. The 
second step is the alignment of the myoblasts into chains and the following fusion. 
Fusion is mediated by metalloproteinases called meltrins. As the myoblasts 
become capable of fusion, another myogenic bHLH protein, myogenin, becomes 
active. Myogenin binds to the regulatory regions of several muscle-specific genes 
18 
and activate their expression. Instead, myostatin, a member of the TGF-B family 
of paracrine factors
23
 is a negative regulator of myogenesis, is. 
 
 
Figure 10. Myogenesis. 
Myogenesis occurs following a precise 
scheme. Stem cell maintenance is mediated 
by the prolonged expression of Pax3 and 
Pax7 then the cell starts to express myogenic 
transcription factors like MyoD and Myf5. 
These signals cooperate to induce muscle 
differentiation, because they promote the 
activation of myogenin. When muscle 
specific proteins are expressed myoblasts 
fuse and myotubes are formed. Image 
modified from
24. 
 
1.2.2.4 Muscle cell maintenance: satellite cells 
The mechanisms responsible for the maintenance and regeneration of skeletal 
muscle were unclear until the discovery that a population of satellite cells, so-
called because of their position on the edge of the fibers, existed between the 
basal lamina and its sarcolemma of the muscle fiber. Although satellite cells 
constitute 2-5% of the nuclei enclosed by the basal lamina, they have a critical 
role in muscle regeneration that was described only recently
19
. Satellite cells are 
not a homogeneous population; they do not fuse but instead remain potentially 
available throughout adult life. In satellite cells, the combination of Pax3 and 
Pax7 expression does not allow activation of bHLH transcription factors. MyoD is 
not expressed and Pax7 protects the satellite cells against apoptosis. Satellite cells 
that express Pax7 but not Myf5 (Pax7
+
/Myf5
-
) appear to be able to divide 
asynchronously and produce two types of cells: Pax7
+
/Myf5
-
 stem cells and 
Pax7
+
/Myf5
+ 
satellite cells which can differentiate into muscle. Injury or exercise 
can causes satellite cells to enter the cell cycle, produce bHLH transcription 
factors, and fuse with the existing muscle fibers in three or four days. Therefore 
satellite cells are both necessary and sufficient for effective regeneration of 
damaged skeletal muscle
23
. 
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1.3 LncRNAs in skeletal muscle 
 
The functions of many lncRNAs are still poorly understood, however, 
there are many evidences that they take part of the muscle regulatory network and 
are critical regulators of muscle differentiation
4
. 
 
H19 lncRNA was the first lncRNA described in mammalian cells. It is 
transcribed from the maternal allele of H19/Igf2 locus and produces a lncRNA 
highly expressed in developing embryo and adult muscle, both in human and 
mouse. H19 contains several binding sites for the miRNA let-7 family, and may 
act as a miRNA “sponge” for the members of this family4. The depletion of H19 
causes precocious muscle differentiation, a phenotype that is recapitulated by let-7 
overexpression; high let-7 levels are in fact associated with increased cellular 
differentiation, so probably H19 inhibits let-7 activity, thereby preventing 
precocious differentiation
2
. 
 
DRR 
RNA and 
CE
RNA lncRNAs. Many nuclear lncRNAs regulate the activity of 
enhancers, regulatory elements involved in proper temporal and tissue specific 
expression of protein-coding genes. The finding that eRNAs may have a key role 
in the regulation of muscle differentiation is recent: for instance, they are involved 
in the regulation of MyoD
4
. In two enhancer regions of the MyoD gene, the Distal 
Regulatory Regions (DRR) and the Core Enhancer (CE), two enhancer-associated 
lncRNAs, 
DRR
RNA, and 
CE
RNA, were identified. 
CE
RNAs facilitate the occupancy of RNA Polymerase II in cis by increasing 
chromatin accessibility (Figure 11), stimulating the expression of MyoD, while 
DRR
RNAs function in trans to promote the expression of Myogenin. These eRNAs 
seem provide a positive feedback mechanism to reinforce the myogenic 
differentiation commitment upon satellite cell activation
14
. 
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Figure 11. Mechanism of action of eRNAs. 
Enhancer RNAs can allow polymerase accession in a promoter 
region to favour gene transcription. Image modified from
25
. 
 
 
SRA lncRNA. LncRNAs control gene expression not only modifying chromatin 
accessibility to RNA polymerase, but also by directly modulating the activity of 
sequence-specific transcription factors. This is the case for Steroid receptor RNA 
activator (SRA) lncRNA, the first example of lncRNA regulating myogenesis. It 
acts as a scaffold (Figure 2b), bringing together multiple factors that modulate 
gene expression, including MyoD. In muscle, a complex composed by SRA, 
MyoD and the RNA helicases p68 and p72 is present during myogenesis. The two 
helicases are co-activators required for transcription of MyoD targets genes and 
for muscle differentiation. The SRA gene produces multiple transcripts through 
alternative splicing; the retention of the intron 1 generates the long non-coding 
SRA, instead the spliced form generates an open reading frame that code for the 
SRA protein (SRAP). The ratio SRAP/SRA varies during muscle differentiation: 
SRAP mRNA is more abundant in myoblasts, while SRA lncRNA is more 
abundant in myotubes. SRAP is an RNA binding protein that specifically binds 
SRA lncRNA, thus preventing SRA-mediated regulation of MyoD transcriptional 
activity. The correct balance between coding and non-coding SRA molecules is 
important for normal muscle differentiation (e.g. aberrant SRA splicing occurs in 
myotonic dystrophy patients)
4
. 
 
Glt2/Meg3 lncRNA. The Dlk1-Dio3 region is a very complex imprinted locus 
involved in tissue growth regulation and human cancer
4
. The locus contains genes 
for protein-coding RNAs, lncRNAs, miRNAs and snoRNAs both in mouse and 
human. Glt2/Meg3 is a lncRNA originating from this locus that acts in cis. It 
binds and recruits Polycomb Repressive Complex 2 (PRC2) to repress 
transcription of the protein coding gene Dlk1 and of Glt2-as, another lncRNA 
encoded by the same locus. The knockout of Glt2/Meg3 lncRNA results in 
perinatal lethality with defects in skeletal muscle development
14
. 
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Yams lncRNAs. Yin Yang 1 (YY1) is a multifunctional transcription factor 
whose gene is located in the vicinity of Glt2/Meg3 lncRNA and that regulates 
various processes of development and differentiation. It is highly expressed in 
proliferating myoblasts and gradually downregulated when differentiation starts. 
YY1 is well known to play a dual role since it can act as repressor or activator of 
transcription depending on the recruited cofactors
26
. YY1 regulates a family of 
lncRNA known as Yams (YY1-associated muscle lncRNAs) that show distinct 
expression patterns during myogenesis and affect muscle differentiation. While 
Yam-2 and Yam-3 promote muscle differentiation, Yam-1 and Yam-4 are negative 
regulators of myogenesis. Interestingly, Yam-1 displays a cis effect on the 
expression of neighbouring genes like those encoding for miR-715. This miRNA 
targets Wnt7b in skeletal muscle
14
. 
 
LincRNA MD1. One of the first lncRNA identified with a role in myogenesis 
was linc-MD1 (long non-coding RNA, muscle differentiation 1). It is expressed in 
a specific temporal window and was shown to activate late stages of the myogenic 
program by functioning as a ceRNA (Figure 6). It acts as a molecular sponge for 
miR-133 and miR-135. Through this mechanism it promotes the expression of 
MEF2C and mastermind-like protein 1 (MAML1), two transcription factors with 
important role in muscle differentiation
2,4
. 
 
LncRNAs containing SINE elements. LncRNAs containing SINE elements 
regulate the stability of several mRNAs encoding for protein with a role in muscle 
differentiation. During myogenesis, the efficiency of nonsense-mediated mRNA 
decay (NMD) decreases, while the efficiency of Staufen-mediated mRNA decay 
(SMD) increases. These are in fact competitive pathways playing both an 
important role in muscle differentiation. Myogenin and PAX3 are differentially 
targeted by these two pathways of degradation and this different susceptibility 
contributes to their relative abundance during differentiation. PAX3 mRNA is an 
SMD target and its increased decay promotes myogenesis, whereas decreased 
degradation of the NMD target myogenin is required for myogenesis. 
 
Malat1 lncRNA. Metastasis-associated lung adenocarcinoma transcript1 
(Malat1) was one of the first cancer-associated lncRNAs discovered. Malat1 
localizes to bodies known as nuclear speckles, where it regulates alternative 
splicing and gene expression at the molecular level
10
 interacting with the 
epigenetic repressor Polycomb protein Cbx4 and with the SR family of splicing 
factors. Malat1 has a role in the transition from the proliferative phase to the 
22 
permanent cell cycle, as well as in the commitment to differentiation. Moreover, 
recently it was found as a novel downstream target of myostatin. 
 
 
1.4 LncRNA associated to skeletal muscle diseases 
Considering the wide range of roles that lncRNAs play in cellular 
networks, it is not surprising that non-coding RNAs have been implicated in 
disease. Genome-wide association studies have revealed that a great number of 
diseases or traits associated to diseases reside outside of protein coding genes. A 
direct involvement of lncRNAs is demonstrated nowadays for some pathologies. 
Skeletal muscle mass can be markedly reduced through a process called atrophy. 
Atrophy is characterized by the reduction of fiber volume, a decrease in protein 
content, fiber diameter, force production, and fatigue resistance. During atrophy, 
enhanced protein breakdown is the primary cause of the rapid loss of muscle 
proteins. Atrophy is a complex modification occurring in skeletal muscles as a 
result of a variety of causes, from mutations in genes related to muscle function, 
to others diseases that have repercussions on muscle activity. Alterations in the 
activity of the IGF-1/Akt/FoxO and myostatin pathways seem to play key roles in 
skeletal muscle growth, causing atrophy or hypertrophy. Neurodegenerative 
diseases are hereditary and sporadic conditions characterized by progressive 
nervous system dysfunction. These disorders are often associated with atrophy of 
the affected central or peripheral structures of the nervous system. They include 
diseases such as Alzheimer's disease and other dementias, brain cancer, 
degenerative nerve diseases, encephalitis, epilepsy, genetic brain disorders, 
Parkinson's disease, multiple Sclerosis, Amyotrophic Lateral Sclerosis (ALS), 
Huntington's disease, Prion diseases, and others. 
 
Atrophy induced by denervation. Denervation consists of a loss of communication 
between nerve and skeletal muscle that cause a strong reduction of muscle fiber 
dimensions. This can happen as a result of muscle/nerve injury or can be related 
to muscle/nerve pathologies. Skeletal muscle denervation causes muscle atrophy 
via complex molecular mechanisms that are not completely understood. Muscle 
fibers that lose innervation show a characteristic shrivelled and angular shape. 
Denervation atrophy progresses rapidly during the initial stages of disease, and 
myofibers result as an ensemble of cellular nuclei without sarcoplasma. 
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Duchenne muscular dystrophy (DMD). DMD is the most common and severe 
myopathy. It is an X-linked recessive inherited pathology and is characterized by 
severe muscle wasting from early childhood that usually arises in leg and pelvic 
muscles, and later extends to the trunk of the body, compromising the heart and 
respiratory muscles. DMD is caused by mutations in the Dystrophin gene. 
Recently, lncRNAs were found to be transcribed from intronic sequences of 
Dystrophin gene, thus demonstrating a concomitant expression of lncRNAs with 
dystrophin
4
. 
 
Facioscapulohumeral muscular dystrophy (FSHD). FSHD is the third most 
common type of muscular dystrophy. It results in a more restricted pattern of 
muscular weakness compared with DMD, mainly confined to the facial mimic and 
shoulder girdle muscles but extending to abdominal and leg muscles in the most 
severe cases. The genetic cause affects the copy number of the 3.3Kb 
macrosatellite D4Z4 mapping at the subtelomeric region of chromosome 4. FSHD 
patients carry strong deletions of repeated units causing profound change in the 
epigenetic status. Recently, a lncRNA was identified that, selectively synthesized 
by FSHD patients, promotes the depletion of the locus associated with FSHD 
contributing with pathogenesis
4
. 
 
Amyotrophic lateral sclerosis (ALS). Amyotrophic lateral sclerosis is a term 
used to cover the spectrum of syndromes characterized by progressive 
degeneration of motor neurons. It causes progressive and cumulative physical 
disabilities, and leads to death due to respiratory muscle failure. In ALS, both the 
upper motor neurons and the lower motor neurons degenerate or die, ceasing to 
send messages to muscles. Unable to function, the muscles gradually weaken, 
waste away, and twitch. ALS is heterogeneous in its presentation, course, and 
progression. We do not yet fully understand the causes of the disease, nor the 
mechanisms for its progression. Unfortunately, there is no definitive diagnostic 
test for ALS; often disease progression is a pre requisite
27
. LncRNAs have been 
associated with ALS, most notably Neat1 was shown to modulate the functions of 
ALS-associated RNA-binding proteins during the early phase of ALS
28
. 
Recognition of the roles of lncRNAs in human disease has unveiled new 
diagnostic and therapeutic opportunities. Advances in lncRNA genetic study will 
probably led to new therapeutic approaches. 
24 
1.5 miRNAs involved in muscle physiopathology 
Several miRNAs have been identified to directly influence muscle 
development. Most miRNAs modulate the status of quiescent satellite cells and/or 
myogenic activation by directly targeting Pax3/7, the master transcription factors 
that maintain satellite cell quiescence. For example, miR-31 in satellite cells 
maintains the quiescence state by sequestering Myf5 mRNA in the nucleus. 
The miR-1/206 family is capable of promoting myogenesis, in part by inhibiting 
Pax3/7 in embryonic muscle precursors and satellite cells, instead miR-186 targets 
myogenin and thus inhibit terminal muscle differentiation. MiR-675-3p is another 
recently identified miRNA that promotes muscle differentiation by targeting 
Smad1 and Smad5. This miRNA is encoded in the exon of H19 lncRNA, which 
also plays a critical role in myogenesis. MyomiRs are defined as muscle specific 
miRNAs and particularly interesting miRNAs in this category are those codified 
from intronic regions of the MyHC genes (Myh6, Myh7 and Myh7b). Those that 
play important roles in regulating muscle myosin isoforms and therefore muscle 
fiber type are miR-208a, -208b, and -499. MiR-208b, and -499 repress fast 
myofiber genes while activates slow muscle specific genes. The effect is mediated 
by targeting transcriptional repressors of slow muscle fiber genes, such as Sox6
14
. 
MiR-133 family (miR-133a-1, -133a-2 and -133a-3) is also critical for both 
skeletal and cardiac muscles development. 
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Chapter 2 – Aims of the thesis 
 
 The aim of this thesis was to identify the subcellular localization of all 
long non-coding RNAs (lncRNAs) expressed in fast and slow myofibers and then 
relate them with the pathophysiological models of skeletal muscle. LncRNAs are 
emerging regulators of many biological processes; they are prevalently studied in 
cancer and only a small group of lncRNAs has been studied in skeletal muscle. 
Since lncRNA functions are related to their subcellular localization and 
expression, our analysis were focused on defining both these aspects at the single 
cell level. 
In previous microarray experiments we collected lncRNA expression data 
associated with differential RNA extraction from purified nuclei and cytoplasm; 
in this thesis we analysed the expression data and showed that lncRNAs can 
localize specifically in nuclei or cytoplasm of myofibers isolated from either 
Soleus, Tibialis Anterior (TA) or Extensor Digitorum Longus (EDL). In order to 
validate this analysis, we performed Fluorescence In Situ Hybridization (FISH) 
experiments. This allowed the analysis of subcellular localization of specific 
lncRNAs in skeletal muscle tissue sections also evidencing their fine 
regionalization inside the nuclei. 
Skeletal muscle, together with liver and earth, is one of the most important tissue 
regulating mammalian metabolism; we analysed the expression of a group of 
lncRNA in these tissues in order to identify those lncRNA that were preferentially 
expressed in skeletal muscle. 
Different types of skeletal muscle can present different types of metabolism; they 
can be divided in slow-contracting muscles (oxidative metabolism) or fast-
contracting muscles (glycolytic metabolism) depending on their different 
myofiber composition. For this reason we also analysed the expression of 
lncRNAs in single myofibers and compared the expression in slow-twitching 
single myofibers with the expression in fast-twitching myofibers.  
Since it is tricky to induce lncRNA down- or up-regulation in-vivo it is important 
to have in-vitro systems where studied lncRNA have the same subcellular location 
of in-vivo. We used the model cell line C2C12, routinely used to mimic muscle 
development, and analysed the expression of lncRNAs in C2C12 cells 
differentiation. 
Specific roles for lncRNAs have been documented in different diseases, but no 
data are available on skeletal muscle atrophy. Skeletal muscle atrophy is a severe 
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disease affecting a large amount of people in the world, its development can be 
linked with many different factors like cancer, bed rest, and ageing and the 
identification of potential regulators could improve the development of new drugs 
able to counteract effects of this invalidating aspects of life. We evaluated the 
expression of lncRNAs in different atrophy models: denervation or starvation 
induced atrophy and amyotrophic lateral sclerosis (ALS) to identify common or 
specific induced/repressed lncRNAs.  
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Chapter 3 – Materials and Methods 
 
3.1 Genome-wide approach for long non-coding RNAs localization 
LncRNAs have different functions in relation to their subcellular location. 
As discussed in Chapter 1, nuclear lncRNAs can influence gene expression 
modulating chromatin architecture or interacting with transcription factors, while 
cytoplasmic lncRNAs can function as sponges for miRNAs. It is important to 
study subcellular location of as many lncRNAs as possible in order to understand 
their role and function. For this reason we adopted a genome wide approach 
associating specific nuclear or cytoplasmic RNA extraction with microarray 
technique. 
 
3.1.1 Statistical analysis: Significance Analysis of Microarrays (SAM) 
In order to define subcellular localization of lncRNAs we identified differentially 
expressed lncRNAs between nuclear and cytoplasmic RNA preparations derived 
from the same fiber pool. Differentially expressed lncRNAs were identified 
according to Significance Analysis of Microarrays (SAM) analysis
29
 implemented 
in T-MeV suite
30
 also used to produce heat maps. 1% of false significant genes 
were considered in this analysis. LncRNAs most expressed in the nucleus were 
considered as nuclear, while those most expressed in the cytoplasm were 
considered as cytoplasmic. 
 
3.1.2 Validation of the genome wide lncRNA subcellular localization 
To validate the genome-wide approach we selected about 30 lncRNAs to 
analyse their localization with two alternative techniques: the qRT-PCR 
associated with nuclear and cytoplasm fractionation and the Fluorescent In Situ 
Hybridization (FISH). We selected lncRNAs which were identified as being 
localized in the nucleus, in the cytoplasm or that didn’t show a specific 
localization. 
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3.2 C2C12 Cell Culture 
C2C12 myoblast cell line was chosen as in vitro model of skeletal muscle 
differentiation. Cultures were used for both RNA extraction and FISH analisys. 
 
3.2.1 Thawing 
Frozen aliquots containing 10
6
 C2C12 myoblasts were quickly thawed in a 
37° C water bath. Cells were diluted slowly with pre-warmed (37° C) proliferative 
medium (DMEM supplemented with 10% FBS and 1% Penicillin; ThermoFisher 
Scientific) and then centrifuged at 300 g for 5 min. 
Pellet containing the thawed C2C12 myoblasts was resuspended in 10 ml of 
proliferative medium and plated on a 10 cm diameter Tissue Culture petri dish. 
 
3.2.2 Propagation 
Plated C2C12 cell cultures were maintained proliferating in an incubator at 
37° C with high humidity and 5% CO2. To avoid spontaneous differentiation, the 
cells were detached every 2-3 days, upon reaching ~80% confluence, using 
Trypsin-EDTA 0.25%. Detached cells were plated with a 1:10 dilution. 
 
3.2.3 Differentiation 
Differentiation of the C2C12 myoblasts into myotubes was induced switching 
the growth medium from proliferative medium to differentiative medium (DMEM 
with 2% HS and 1% Penicillin; ThermoFisher Scientific) when the cell culture 
reached confluence. Once switched to differentiative medium the C2C12 were 
monitored daily and the medium was changed every day. The first myotubes were 
evident after 3 days in differentiative medium. 
 
3.2.4 Cryopreservation 
C2C12 were cryopreserved in order to stock the culture. Cells were detached 
using Trypsin-EDTA and centrifuged to remove all proliferative medium; the 
pellet was then resuspended in FBS with 10% DMSO and stored in aliquots of 10
6
 
cells at -80° C. 
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3.2.5 Nuclei purification from C2C12 cultures 
To separate the nuclei from the cytoplasm, C2C12 cell cultures were washed 
two times with ice-cold PBS buffer and then lysed with ~550 μl of RLN buffer 
prepared as follow: 50 mM Tris-HCl pH 8.0, 140 mM NaCl, 1.5 mM MgCl2, 
0.5% (v/v) Triton X-100 (1.06 g/ml). 
Just before use, it was added with 1,000 U/ml of RNase inhibitor. In order to 
assure complete lysis, RLN solution containing the cell suspensions were passed 
repeatedly through a syringe needle (0.45 mm of diameter) and the result was 
checked at the microscope with the addition of trypan blue and DAPI. 
Nuclei were then pelleted via low speed centrifugation (3 minutes at 6,000 g) and 
cytoplasmic fractions (surnatants) were moved to new microcentrifuge tubes to be 
concentrated with a vacuum-pump centrifuge. 
After volume reduction of cytoplasmic fractions, 1 ml of Trizol (ThermoFisher 
Scientific) was added both to purified nuclei and cytoplasmic fractions and 
solution were stored at -80° C until needed for the RNA extraction. 
 
 
3.3 RNA Extraction from single myofibers 
 
3.3.1 Enzymatic dissociation of myofibers from whole muscle  
We modified published methods for long fibers isolation31–33 in order to keep 
the digestion time as short as possible and avoid activation of stress response 
genes. Muscles from both hind limbs of the same mouse were immediately 
removed by microdissection, taking care to handle them only by their tendons to 
minimize mechanical damage to the fibers. Digestion proceeded for 40 – 45 min. 
at 37° C in 1 ml high-glucose Dulbecco's modified Eagle medium (DMEM; 
ThermoFisher Scientific) containing 10 mg type I collagenase (220 U/mg; 
Sigma). The collagenase-treated muscles were sequentially rinsed for 2 min. in 3 
ml of DMEM, 3 ml DMEM supplemented with 10% fetal bovine serum (FBS) 
and 3 ml of DMEM and finally transferred into 50 mm x 18 mm well containing 3 
ml of DMEM with 10% FBS. Single myofibers were liberated by gentle physical 
trituration with a wide-mouth plastic Pasteur pipette (about 4 mm diameter). The 
triturating process was repeated until several intact fibers were obtained. After 
each physical trituration, the muscles were transferred in a new well, to get rid of 
collagen wisps and hyper-contracted fibers. Quickly, intact and well-isolated 
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fibers were picked under stereo-microscope and washed first in DMEM and then 
in PBS. All samples were collected within 45 min. from the last trituration step. 
 
3.3.2 Total RNA extraction from single myofibers 
Total RNA was extracted from fibers using the silica membrane technology of 
RNeasy Micro Kit (Qiagen). Single fibers were disrupted by adding 500 µl of 
Trizol (ThermoFisher Scientific) and lysate was homogenized by vortexing for 5 
min. The protocol used was essentially the one suggested by the manufacturer, 
with the following modification: RNA elution was performed with 14 µl 
RNase-free water pre-heated at 37° C and repeated a second time to avoid loss of 
RNA in the column. Due to the dead volume of the column, we recovered about 
20 – 24 µl. We estimated that the amount of total RNA purified from a single fiber 
is in the range of one to few nanograms. 
 
3.3.3 Total RNA extraction from tissue samples and cell coltures 
All tissue samples were homogenized in sufficient Trizol (ThermoFisher 
Scientific) volume to avoid RNA degradation. Pelleted C2C12 nuclei and 
cytoplasm were prepared as previously described, while 30 mg of each tissue 
sample were homogenized in 1 ml of Trizol (ThermoFisher Scientific). To each 
tube were added 200 µl of chloroform per ml of Trizol (ThermoFisher Scientific) 
and mixed well by inverting the tube. 
After an incubation of 20 min. on ice, the samples were centrifuged at 13,000 g 
for 20 min. at 4° C. The resulting aqueous phase (~ 400 µl per ml of Trizol) was 
transferred to a clean microcentrifuge tube paying attention do not recover 
material from the lower phase. An equal volume of isopropanol was added and the 
resulting mix was stored at -20° C overnight. To precipitate all RNA present in 
the solution it was centrifuged at 13,000 g for 30 min. at 4° C. Supernatant was 
removed and RNA pellet was washed with 500 µl of ice-cold 80% Ethanol in 
water. Following another centrifugation (13,000 g at 4° C for 10 min.) pellet was 
air dried, resuspended in RNase free water and stored at -80° C until needed. 
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3.4 RNA quality control 
RNA extracted from single fibers, C2C12 nuclei and cytoplasm fractions 
and tissues was quantized using nanodrop (Celbio) spectrophotometer and 
analysed using the RNA 6000 Pico or Nano LabChip on a 2100 Bioanalyzer 
(Aligent). The sample (1 µl) was separated electrophoretically as described by the 
manufacturer and data was displayed as a gel-like image and/or an 
electropherogram. All poor quality RNA samples were discarded. 
 
 
3.5 RNA retro-transcription 
RNA extracted as previously described was reverse transcribed into its 
complementary DNA (cDNA) in a retro-transcription reaction using SuperScript 
II Reverse Transcriptase (ThermoFisher Scientific). We followed the 
manufacturer’s protocol but used both oligo dT and random hexamers as primers 
for the reaction. This allows the retro-transcription of RNAs do not present 
poly(A) tail. cDNA obtained was precipitated adding 1/10 volumes of sodium 
acetate and 2.8 volumes of absolute ethanol, centrifuged at 13,000 g for 20 min. at 
4° C and resuspended in nuclease free water. 
 
 
3.6 Primers for qRT-PCR and FISH analyses 
Primers were designed using the web tool Primer3 from 
http://biotools.umassmed.edu/bioapps/primer3_www.cgi. qRT-PCR primers were 
chosen to amplify a small region (between 60 and 130 base pairs) while primers 
used to prepare FISH probes were chosen to produce a bigger amplicon (between 
500 and 700 base pairs). In both cases, primers were designed to amplify the same 
isoforms the microarray probes identified as differentially localized between 
cytoplasm and nucleus (see paragraph 3.6). An example of isoform specificity for 
qRT-PCR, FISH primers and microarray probes for lncRNA A330023F24Rik is 
shown in Figure 12. For this reason we used transcript sequences downloaded 
from Ensembl database. 
 In order to check the stability of secondary structures as well as the stability of 
primer dimers, prier sequences were analysed using the online tool Oligo 
Analizer, from http://eu.idtdna.com/calc/analyzer. The list of primers used is 
included in Supplementary Table 1. 
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Figure 12. Genome location of probes for FISH, microarray and qRT-PCR analyses. 
Comparison between the region targeted by microarray probe and the regions amplified using 
qRT-PCR or FISH primers. 
 
 
3.7 Real Time Analysis 
Real-Time analysis was performed in a 7500 Real-Time PCR System 
(Applied Biosystem) using HOT FIREPol EvaGreen qPCR Supermix (Solis 
BioDyne). Real-Time analysis was performed following the manufacturer’s 
instructions and using 10 ng/reaction of cDNA as template. PCR cycle was 95°C 
12 min.; 95°C 15 sec, 60°C for 20 sec, 72°C 35 sec for 40 cycles and finally the 
dissociation step. Delta Ct method was used to identify differentially expressed 
coding and non-coding RNAs. As reference genes were used Tbp, Tnx1 and B2m. 
The list of primers used is included in Supplementary Table 1. 
 
 
3.8 PCR amplification - synthesis of probes for FISH analysis 
For each target transcript, a region of about 600 nucleotides was cloned via 
TA ligation into a pCR™II-TOPO® vector (ThermoFisher Scientific), which is a 
high copy number E. coli plasmid with SP6 and T7 promoters on 5’ and 3’ end of 
clonal site. TA ligation is based on the terminal transferase activity of Taq 
Polymerase that add at the end of amplicons preferentially adenines. PCR 
amplification cycle used to produce amplicons was: 95°C 10 min., 95°C 20 sec., 
59°C 30 sec., 72°C 1 min., for 40 cycles and 72° C 12 min. 
No purification of PCR was performed before cloning. The orientation and 
sequence of the insert was checked via Sanger sequencing (BMR genomics). After 
linearization of the plasmids (see supplementary Table 2), probes were synthetized 
via in-vitro transcription using Amino Allyl UTP (in addition to conventional 
NTPs). This allowed us to couple the resulting 600 nucleotides probes with either 
modified Cy3 or Cy5 fluorophores. To remove unincorporated reagents the aRNA 
solution was purified using MEGAclear™ Transcription Clean-Up Kit 
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(ThermoFisher Scientific). Purified probes and incorporated fluorophores were 
quantized using nanodrop (Celbio) spectrophotometer. 
Fluorescent probes were then chemically fragmented using the RNA 
Fragmentation kit (ThermoFisher Scientific) to obtain a final size for the probes 
comprised between 50 and 150 nucleotides. Probes complementary to the target 
RNA sequence were used to detect the presence of the transcript in the samples 
while probes with the sense sequence were used as negative controls. 
In the Supplementary Table 2 can be found a complete list of the enzymes used in 
each linearization reaction for each target gene. 
 
 
3.9 Fluorescence in situ hybridization (FISH) 
FISH experiments were performed on C2C12 proliferating and 
differentiating myoblasts and on tibialis anterior muscle (TA) transversal sections. 
C2C12 myoblasts were seeded on 18 x 18 mm coverslips treated with 70% EtOH 
(Sigma-Aldrich), fixed with 4% PFA in PBS and then dehydrated using increasing 
concentrations of ethanol (80%, 90%, 100%). Coverslips were then stored 
at -80°C. Each muscle, after mouse sacrifice, was quickly collected and frozen in 
liquid nitrogen. 20 µm thick sections were cut using a Leica CM 1850 cryostat 
at -21°C, divided in groups of three laids on SuperFrost Plus slides (Thermo 
Scientific) and stored at -80° C. Prior to a FISH experiment, muscle sections were 
thawed at room temperature and fixed with 4% PFA. 
Both C2C12 cell cultures and muscle sections were permeabilized in 70% ethanol 
at -20° C prior incubation with the FISH probe, for at least 2 hours (C2C12) or 
overnight (muscle sections). 1 µg of probe was used to treat each C2C12 culture 
coverslip or muscle section. Hybridization step was performed overnight in a 
humid environment at 30° C. Samples were then washed and treated with RNaseA 
to remove excess of probe. Nuclei were stained using DAPI and samples where 
mounted using Fluoromount mounting medium (Sigma-Aldrich) to preserve the 
fluorescence of the probes. Images were acquired with Leica TCS SP5 confocal 
laser microscope. 
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3.10 Functional analysis of mRNA correlated with lncRNAs 
To better understand Pvt1 activity in skeletal muscle, coding and lncRNA 
Pvt1 were correlated according to their expression. Pearson correlation was used 
and only nuclear abundant mRNAs were considered in this analysis. Nuclear 
abundant mRNAs were identified using the same analysis performed for 
lncRNAs. Enrichment analysis of Pvt1 correlated mRNA were performed using 
the web tool DAVID34. 
 
 
3.11 Animals 
Wild-type CD1 mice (Charles River) were housed in a normal 
environment provided with food and water. Adult females were killed by rapid 
cervical dislocation, to minimize suffering, at three months age (weight: 33-35 g). 
Fasting was performed as previously described, by removing chow with free 
access to water35. Denervation experiments were performed by cutting the sciatic 
nerve of one limb while the other was used as control. Mice were sacrificed after 
3, 7 or 14 days after denervation. Mice expressing mutants SOD1G93A (glycine 
substituted to alanine at position 93) develop motor neuron disease that resembles 
features of amyotrophic lateral sclerosis (ALS). We used this mouse model to 
mimic atrophy derived from ALS. 
 
 
3.12 Ethics statement 
All aspects of animal care and experimentation were performed in 
accordance with the Guide for the Care and Use of Laboratory Animals published 
by the National Institutes of Health (NIH Publication No. 85-23, Revised 1996) 
and Italian regulations (DL 116/92) concerning the care and use of laboratory 
animals. Experimental procedures were approved by the local Ethical Committee 
of the University of Padova. 
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Chapter 4 - Results and Discussion 
 
4.1 Genome-wide analysis 
To define the subcellular localization and fiber specificity of long non-
coding RNAs (lncRNAs), different microarray expression data sets were analysed 
using the Significance Analysis of Microarrays (SAM) algorithm. 
 
4.1.1 LncRNA subcellular localization 
A total of 1,433 lncRNAs were found to be preferentially localized in one 
subcellular compartment (Figure 13). 655 are more expressed in the cytoplasm, 
and 481 in the nucleus. A third category, represented by 297 lncRNAs, shows a 
different localization in relation to the type of muscle analysed (EDL, SOL or TA) 
or in relation to the different lncRNA isoform. A relatively large number of 
lncRNA (45%) was found to preferentially localize in the cytosol, in accordance 
with the previous observation made by Van Heesch, S. et al in human colon 
cancer cells
36
. Interestingly, skeletal muscle specificity of lncRNA expression is 
lesser than sharing. This could be in accordance with the fact that a small number 
of lncRNAs is needed to specify for different metabolism, or that most function of 
different muscles are related and therefore most lncRNAs share the same 
localization. 
 
Figure 13. Classification of nuclear and cytoplasmic lncRNAs. 
481 lncRNAs localize prevalently in the nucleus, while 655 in the cytoplasm of soleus, EDL and 
TA derived myofibers. 297 lncRNAs have a mixed localization. Most lncRNAs share the same 
localization albeit derived from different myofibers, while a small number evidence a fiber 
specification. 
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4.2 Validation of the genomewide analysis 
In order to validate the results obtained with our genome wide approach, 
we analysed the localization of lncRNAs via Fluorescent In Situ Hybridization in 
both skeletal muscle (TA) tissue sections and cell cultures (C2C12). 
 
4.2.1 Fluorescent In Situ Hibridization 
Fluorescence In Situ Hybridization (FISH) is a technique that allows to 
target a specific sequence with a fluorescent probe.. It consists in the hybridization 
of a DNA or RNA probe to its complementary sequence on tissue slides or fixed 
cell cultures. and it can be used to detect both DNA and RNA targets., We used 
FISH to target 7 lncRNAs transcripts chosen among those showing differential 
nucleus-cytoplasm localization
37
. 
Using FISH analysis we were able to confirm what we observed in the previous 
microarray analysis. This result confirms the possibility of using cell compartment 
fractionation in association with genome-wide analyses, such as microarray, to 
infer lncRNA localization. Through FISH analysis we were also able to obtain a 
more accurate localization picture, discriminating between positive and negative 
nuclei in the same image; in many cases we were able to observe also a finer 
subnuclear localization. Not all nuclear compartments are equivalent. In fact, 
nuclei host transcriptional active or inactive DNA regions. The association of 
lncRNAs with one of these regions is useful to infer their possible positive or 
negative action on gene expression. Moreover, FISH on skeletal muscle evidenced 
a prevalent expression of the analysed lncRNA in myofibers and not in other cell 
type composing the muscle. This is in accordance with the microarray analyses 
using single myofibers that allows the removal of muscle non-contractile cells. 
Through this way we produced a more accurate localization and expression 
eliminating a background due to different cell types in muscles. The panels 
included in Figure 14 show the localization of lncRNAs with enlargments of some 
nuclear positive signals. 
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a)  
b)  
c)   
d)  
e)  
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f)   
g)   
 
Figure 14. FISH on skeletal muscle sections and C2C12 myoblasts. 
From left to right are represented probe for lncRNA, magnifications of nuclear signals and 
negative controls (a-d). a) FISH for Gt(ROSA)26Sor that is low expressed and localizes in nuclei; 
b) FISH for Neat1 that localizes in nuclei; c) FISH for H19 that localizes both in nuclei and in 
cytoplasm; d) FISH for Airn that localizes both in nuclei and in cytoplasm. e) FISH for Mir143hg: 
left image represents FISH on tissue slides, the central the FISH on C2C12 cells, and the right the 
FISH with the negative control probe on C2C12. This lncRNA shows a nuclear localization; f) 
Mir22hg: FISH on tissue slides, magnification of nuclei. Also this lncRNA has a low expression g) 
Nctc1-RI: FISH on tissue slides, magnification of nuclei. 
 
 
FISH analysis confirmed the localization predicted by the genome-wide analysis 
for all targeted lncRNA, in skeletal muscle (TA) tissue sections, cell cultures 
(C2C12) or both. Gt(ROSA)26Sor, Neat1, Mir143hg and Nctc1-RI have been 
identified as nuclear long non-coding RNAs while H19 and Airn are found in both 
nucleus and cytoplasm. Mir22hg is prevalently expressed in the cytoplasm or in 
the perinuclear compartment. 
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4.3 In-vitro analysis of lncRNA subcellular localization 
 
Results derived from the analysis of skeletal muscle or single myofibers are 
important to understand the role of lncRNAs in-vivo, but, at the same time, it is 
important to have an in-vitro tool that can be used to characterise lncRNA 
functions. C2C12 cell cultures are a well-established in-vitro model to study 
muscle differentiation. Using these cell cultures, we studied lncRNA subcellular 
localization during muscle differentiation. 
 
4.3.1 Differential RNA extraction from differentiating C2C12 cells 
Microarray and qRT-PCR data production require the extraction of RNA 
independently from nuclei and cytoplasm. We started from the isolation of nuclei 
and tested the quality of the purification before and after the RNA extraction. 
During the isolation of nuclei from muscle fibers or C2C12 cells, we checked if 
purified nuclei were contaminated by fiber fragments or cell debris evidencing 
that no fragments/debris were present (Figure 15). 
 
Figure 15. Nuclei isolated from the fibers. 
To confirm that nuclei used for RNA extraction were not contamined from other cellular debris, 
some images were cought at the microscope. Image shows a clear preparation of purified nuclei. 
 
After RNA was extracted from both nuclei and cytoplasm, a further analysis was 
performed to confirm the quality of the extraction. Using a 2100 Bioanalyzer 
(Agilent) we were able to discriminate between nuclear and cytoplasmic RNA 
according to the presence of specific peaks38.  
We evidenced that extracted RNA extracted was not degraded (Figure 16) and 
more importantly, that there was no contamination of cytoplasmic RNA in the 
nuclear RNA samples (Figure 16) since specific peaks after the 28S band (~ 4,000 
nt) and at 200 nt were found, as expected, in the nuclear RNA and not in the 
cytoplasmic RNA (Figure 16). 
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Figure 16. RNA quality control. 
Good quality of RNA confirmed by 2100 Byoanalyzer. In red is represented cytoplasmic RNA and 
in blue nuclear RNA. Results are in agreement with Trask, H. W. et al.38. 
 
4.3.2 Quantitative Real-Time PCR 
In order to further validate microarray data, the expression of 41 genes (31 
lncRNAs and 10 coding RNAs) was analysed via quantitative Real-Time PCR 
(qRT-PCRs) in different conditions. Coding genes lying in a genomic location 
near one of the analysed lncRNAs were also included (e.g. lncRNA is in antisense 
with coding RNA, lncRNA is codified from an intron of coding RNA). 
 
4.3.3 Comparison between FISH and qRT-PCRs 
LncRNAs expression was analysed separately for nuclei and cytoplasm 
during C2C12 differentiation at five different time points (0, 1, 3, 7, 14 days) in 
order to have a complete picture of their expression and localization during the 
differentiation process. Heat map in Figure 17 shows a) if the lncRNAs tested are 
present only in the nucleus or only in the cytoplasm, or in both compartments, and 
b) if the lncRNAs changes localization during myoblasts differentiation. 
Nuclear lncRNAs are 9530059O14Rik, A330026F24Rik, Dancr, Dnm3os, Gas5, 
Gm11766, Gm11767, Mir143hg, Snhg1 and Snhg7. 
Among protein-coding genes, Sox6 and Cd46 are nuclear. The reason why the 
transcript for a membrane protein (Cd46) that is part of the regulatory 
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complement system is found in the nucleus is not clear. Interestingly, genes for 
Cd46 and lncRNA A330026F24Rik are found in the same genomic region and 
code for transcripts that show the same pattern of localization (99.3% correlation). 
Both transcripts are found in the nucleus in accordance with microarray 
experiments on pools of myofibers from EDL, soleus and TA. Only H19, Igf2os, 
and Snhg6 show a cytoplasmic localization during terminal differentiation. 
Moreover, in agreement with the genome-wide analysis, 2310065F04Rik is found 
in both subcellular compartments. 
Different lncRNAs increase their expression during C2C12 differentiation: 
(1110020A21Rik, 2310065F04Rik, Dlx6os, Gm16062, Nctc1-lnc, Nctc1-RI) as 
well as the protein-coding gene Dio3. Probably these lncRNAs could be involved 
in cell cycle withdrawn, fusion of cells and formation of myotubes. 
The protein-coding gene Myh3 shows a spike of expression at seven days of 
differentiation in both subcellular compartments. Similarly, Neat1 is up-regulated 
in both nucleus and cytoplasm at days 1 and 14 days of differentiation. 
Vice versa, Snhg6 progressively increases in cytoplasm. Snhg6 was classified as 
nuclear lncRNA in the genome-wide analysis but here seems that it is present on 
both compartments, diffusing from nucleus to cytoplasm. 
As stated before for lncRNAs that increase their expression during C2C12 
differentiation, also for the long non-coding and the protein coding genes with a 
precise activation we can speculate that they can have a precise spatio-temporal 
function. 
Interestingly, we evidenced that the localization of lncRNA Pvt1 changes from 
cytoplasmic during cell proliferation (day 0) to nuclear during myoblast 
differentiation. 
This result was later confirmed by FISH analysis as well (Figure 18) and it is 
interesting because Pvt1, a lncRNA well studied in tumours
39
, codify for different 
miRNAs and is able to modulate Myc function
39
. In the cytoplasm it could 
function as a sponge for different miRNAs or is located when it is needed for the 
synthesis of specific miRNAs; while in the nucleus it can participate to 
transcriptional and cell cycle regulation during C2C12 differentiation. 
§
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Figure 17. Expression of lncRNAs during 
C2C12 differentiation considering RNA in 
nuclei and cytoplasm separately. 
Heat map reports the results of qRT-PCRs 
from RNA extracted from C2C12 nuclei and 
cytoplasm. Red squares indicate high 
expression level instead green squares 
indicate low expression level. Column 
names represent the different sources of 
RNA: 
Columns named “N (0, 1, 3, 7, 14) days” 
are relative to RNA extracted from Nuclei at 
0, 1, 3, 7 and 14 days of differentiation; 
Columns named “C (0, 1, 3, 7, 14) days” 
are relative to RNA extracted from 
Cytoplasm at 0, 1, 3, 7 and 14 days of 
differentiation. 
Gene names are marked with (N) if the 
lncRNA resulted to have a nuclear 
subcellular localization. Protein coding 
genes are identified with an asterisk (*). 
 
(N) 
(N) 
(N) 
(N) 
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Figure 18. FISH of Pvt1 during C2C12 differentiation. 
Pvt1 moves from cytoplasm to nuclei during C2C12 differentiation. 
 
 
4.4 Whole tissue qRT-PCR analysis  
To analyse the expression of lncRNAs in different tissues we extracted 
total RNA from mouse heart and liver samples and from two different types of 
muscle (extensor digitorum longus and soleus) and used it in qRT-PCR analysis 
of previously selected lncRNAs for C2C12 differentiation analysis. Samples were 
collected from CD1 wild-type mice (Figure 19). 
       
Figure 19. Tissue collection from CD1 mice. 
From left to right: liver, heart, extensor digitorum longus, and soleus muscles. 
 
Day 0
Control
Nuclei
Day 1
Control
Nuclei
Day 2
Nuclei
Day 3
Control
Nuclei
Control
44 
We evidenced 19 lncRNAs (1110006G14Rik, 2310065F04Rik, 4930509E16Rik, 
9530059O14Rik, A330023F24Rik, Dleu2, Dlx6os, Gas5, Gm11190, Gm16062, 
Gt(ROSA)26Sor, H19, Mir22hg, Mirg, Nctc1-Retained Intron, Nctc1, Neat1, 
Snhg6, Snhg7) that are more expressed in skeletal muscle compared to the other 
tissues (Figure 20). Among these lncRNAs, Dlx6os, Gas5, Gm11190, and H19 
were found to be more expressed in soleus muscle (Figure 20), suggesting that 
their potential role could be specific of slow fibers. Only Gas5 was confirmed to 
be more expressed in isolated slow myofibers (see paragraph 4.5.2). 
Skeletal muscle is a heterogeneous tissue composed by a number of different cell 
types. LncRNA levels calculated by using RNA extracted from whole muscle can 
be substantially different from those found using RNA specifically extracted form 
single or pools of myofibers. In fact, using whole muscle we have an averaged 
expression influenced by blood, neuronal, and endothelial cells, while, using 
single myofibers, this aspect is avoided and the calculated expression is due only 
to the specific analysed cell type.  
1110006G14Rik, 2310065F04Rik, and Snhg6 resulted expressed only in EDL 
muscle (Figure 20). All these lncRNAs resulted prevalently expressed in fast 
myofibers which are typical of EDL muscle (see paragraph 4.5.2). 
Some lncRNAs were found to have a higher expression in striated muscles (EDL, 
Soleus and Heart) rather than liver. This group includes Airn, Dancr, Gm12260, 
Neat1, Igf2os, and Snhg7 (Figure 20). 
Heart specific lncRNAs are Dnm3os, Mir143hg, Gm11766 and its antisense 
Gm11767. 
Finally, lncRNAs exhibiting elevated expression in liver are Pvt1, and 
1110020A21Rik. We found that Pvt1 has a fast-specific expression in myofibers 
(see paragraph 4.5.2). In this analysis, the higher expression in EDL (fast muscle) 
is masked by the greater expression in the liver. Pvt1 association with 
hepatocellular carcinoma was already described by Ding et al. in liver so the 
higher expression in that tissue was expected
40
. 
Interestingly, lncRNA 1110006G14Rik which maps inside one of Sox6 introns 
shows a specific expression in EDL muscle, just like Sox6 does. The connection 
between 1110006G14Rik and Sox6 will be further discussed in paragraph 4.5.2. 
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Figure 20. Heat map evidencing the 
expression of several lncRNAs and 
associated coding RNAs in different 
tissues. 
The heat map shows the tissue specificity of 
lncRNAs and associated protein-coding 
genes. Red squares indicate high expression 
level, instead green squares indicate low 
expression level of the genes tested in the 
four tissues indicated on the top of the image. 
 
A similar situation is represented by the lncRNA 1110020A21Rik and the protein-
coding gene Ppm1b. Even if in this case the lncRNA is coded in the opposite 
strand of the gene, both are highly expressed in soleus, a muscle which is 
prevalently composed by slow oxidative myofibers. Ppm1b gene is known to be 
involved in the control of Pax genes expression (Pax2)
41
. Pax proteins induce 
specific pathways of activation or repression during development and are also 
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involved in myogenesis and muscle cells maintenance. The repressive function of 
Pax proteins is mediated by the recruitment of members of the Groucho co-
repressor family where Ppm1b is an essential component
41
. Ppm1b can inhibit 
H3K4 methylation and therefore gene activation. SINE BASE 
(http://sines.eimb.ru/) analysis of lncRNA 1110020A21Rik predicts the presence 
of SINE sequences; this means that the lncRNA could function as described for 
Uchl1-as. 
In contrast with the previous examples, the protein-coding/lncRNA couple 
Myh3/2310065F04Rik presents a discordant expression pattern. The lncRNA is 
prevalently expressed in EDL, while the associated Myh3 gene is prevalently 
expressed in soleus muscle (Figure 20). This could result from an inhibitory 
function of the lncRNA on the gene. 
Among protein-coding genes, Cops3, Igf2 and Igfr are found to be more expressed 
in striated muscles rather than in liver. 
Insulin growth factor 2 and its receptor are important for cell growth and for the 
development of skeletal muscle and heart tissues. The lncRNAs found in antisense 
to these protein coding genes (Igf2os and Airn) follow their same expression 
pattern suggesting that they could share functions or be part of a common 
regulatory loop. 
Summarizing the whole analysis, we can say that the most analysed lncRNA have 
an elevated expression in the muscle tissue except for two of them (Pvt1 and 
1110020A21Rik). This could be in accordance with the fact that their selection 
derive from high expression in the analysis of single myofibers and enhance their 
importance in the skeletal muscle biology.  
 
 
4.5 Single Fibers 
Skeletal muscle is a heterogeneous tissue composed by a variety of 
different cell types, but only myofibers are responsible for the contractile 
capability. 
Analysing the expression of lncRNAs in single myofibers allows the removal of 
non-contractile muscle cells (fibroblasts, endothelial, nervous, blood cells). Also, 
results can be matched with the type of the single fiber, giving a much more 
precise characterization of lncRNAs expression in myofibers in relation with 
metabolisms. 
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4.5.1 Classification of muscle fibers 
A group of isolated myofibers were prepared from EDL and Soleus muscles, 
as reported in paragraph 3.3, and total RNA was extracted, retro-transcribed and 
analysed with qRT-PCR (see chapter 3). In order to classify these fibers, we 
analysed the expression of myosin heavy chain isoforms (Myh1, Myh2, Myh4 and 
Myh7). Myofibers showing high expression levels of Myh7 were defined as “slow 
myofibers” (Type 1) while those with high expression levels of Myh4 were 
defined as “fast myofibers” (Type 2b). After classification, four fibers of each 
type were selected to be used as biological replicates (Figure 22) to analyse 
lncRNA fiber specificity. The expression of myosin heavy chain genes in the 
selected myofibers is showed in Figure 21. All fast myofibers present high 
expression levels of Myh4 low expression of any other Myh gene; the same profile 
is found for fibers with high expression of Myh7 (slow myofibers). These results 
are in agreement with previous data about muscle fiber classification
16,20–22
. 
 
 
 
 
Figure 21. Myofibers Classification. 
The heat map reports the expression of 
specific myosin heavy chain genes used to 
classify myofibers in slow or fast type. For 
each fiber, the expression of Myh1, Myh2, 
Myh4 and Myh7 genes was tested. Red 
squares indicate high expression level, 
instead green squares indicate low expression 
level. Fiber S1: fiber slow one; Fiber S2: 
fiber slow two; Fiber S3: fiber slow three; 
Fiber S4: fiber slow four; Fiber F1: fiber fast 
one; Fiber F2: fiber fast two; Fiber F3: fiber 
fast three; Fiber F4: fiber fast four. 
 
 
4.5.2 Fiber specificity of lncRNAs 
Expression levels of lncRNAs were analysed in the four slow and four fast 
myofibers chosen as described (see paragraph 4.5.1). 1110020A21Rik, Dancr, and 
Gas5 lncRNAs showed higher expression in slow myofibers, while 
1110006G14Rik, 2310065F04Rik, Gm16062, Pvt1, and Snhg6 lncRNAs showed 
higher expression in fast myofibers (Figure 22). This result is in accordance with 
the analysis performed on whole muscle (EDL and soleus) for all lncRNAs 
48 
(paragraph 4.4). Three protein-coding genes Dio3, Cops3 and Sox6 were also 
found to have a higher expression in fast myofibers, while only one, Myh3, 
showed higher expression in slow myofibers (Figure 22). The expression profile 
of the complete set of all lncRNAs and protein coding genes in single myofibers is 
shown in Figure 22 using a heatmap, or with histograms for specific lncRNA in 
Supplementary Figure 1. Interestingly, not all fibers respond in the same way 
about the lncRNA expression. This could be due to cell specificity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22. Fiber specificity of lncRNAs 
and related coding RNAs. 
The heat map shows the fiber type 
specificity for lncRNAs and protein-coding 
genes. Red squares indicate high expression 
level, instead green squares indicate low 
expression level. Fiber S1: fiber one, type 
slow; Fiber S2: fiber two, type slow; Fiber 
S3: fiber three, type slow; Fiber S4: fiber 
four, type slow; Fiber F1: fiber one, type 
fast; Fiber F2: fiber two, type fast; Fiber F3: 
fiber three, type fast; Fiber F4: fiber four, 
type fast. The names of genes are reported 
on the right. 
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LncRNA Gas5, which is found to be prevalent in slow myofibers, is a member of 
the 5' terminal oligo-pyrimidine gene class. Part of its secondary structure mimics 
the glucocorticoid response element (GRE): it binds the DNA binding domain of 
the glucocorticoid receptor, blocking it
42
. Other receptors such as androgen, 
progesterone and mineralocorticoid receptors can be regulated through Gas5 
binding to GRE. Gas5 is also known to be involved in the control of proliferation 
and cell survival of T-cells through mTOR pathway, an important pathway 
sustaining skeletal muscle hypertrophy. Glucocorticoid receptors are control 
genes with important functions in development, metabolism and immune 
response. 
As previously described, the lncRNA 1110006G14Rik gene is coded from one of 
Sox6 introns. Both are found highly expressed in fast myofibers, suggesting that 
the lncRNA may have a role in the maintenance of fast phenotype just like Sox6. 
Sox6 is known to be involved in the repression of genes that maintain the slow 
phenotype. Sox6 is a member of the Sox family of transcription factors that can 
act either as transcriptional activators or repressors. The transcription factor 
regulates postnatal muscle fiber-type differentiation, muscle performance and 
metabolism. Sox6 acts as direct repressor of slow myofibers genes by binding 
specific sites proximal to loci that encode for myosin heavy and light chains, plus 
the slow fiber-specific isoform of the sarcoplasmic reticulum Ca
2+
 uptake channel 
SERCA (ATP2a2 or SERCA2)
42
. 
Another example of lncRNA/protein-coding gene couple is composed by lncRNA 
Gm16062 whose genomic sequence is antisense of protein coding gene Cops3. 
Both genes are expressed in fast fibers, suggesting a possible connection between 
their transcription. Also, this result is in accordance with previous literature data 
that describe Cops3 as predominantly expressed in cardiac and skeletal muscle 
(Figure 20). COP signalosome complex (CSN) is involved in various cellular and 
developmental processes. The CSN complex is an essential regulator of the 
ubiquitin (Ubl) conjugation pathway, important in atrophy. For this reason further 
analyses will be needed to evaluate the expression of Cops3 and related lncRNA 
to better explain their function. 
Highly expressed in fast fibers is also Pvt1. This gene has been identified as a 
candidate oncogene. In fact, the over-expression in humans was linked to the 
development of different types of cancer like, for example, breast and ovarian 
cancer or acute myeloid leukemia
43
. 
LncRNA Pvt1 is involved in the regulation of the proto-oncogene Myc to promote 
tumorigenesis. Its gene is found in a region near Myc on chromosome 15 in mouse 
(chr 8 in Homo sapiens) that has numerous physiological functions (e.g. apoptosis 
regulator, oncogene). 
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To understand the activity of Pvt1 we correlated its expression with coding genes 
(see paragraph 4.7). 
 
 
4.6 Skeletal muscle atrophy 
Skeletal muscle atrophy (or wasting) is known to accompany various chronic 
illnesses as well as the aging process reducing muscle mass and function. In order 
to study lncRNAs role in muscular atrophy in vivo we chose three different mouse 
models of atrophy: denervation, Amyotrophic Lateral Sclerosis (ALS) and 
starvation. 
 
 
4.6.1 Denervation 
Atrophy of skeletal muscle can arise as a consequence of denervation due to 
the lack of communication between skeletal muscle and nerve. This process 
appears to be associated to aging and ALS and can be induced surgically by 
cutting the sciatic nerve of one limb.  
During normal conditions, muscles experiment a constant protein turnover 
that is altered during atrophy; proteins are not correctly re-established and as a 
result muscle loses mass and strength. Atrophied muscles are characterized by 
substantial decrease in muscle fiber cross-section area and number, protein 
content and overall contractile strength. Increased fatigability and insulin 
resistance are also observed as a consequence of atrophy. 
Analysing the expression of lncRNAs during muscle atrophy could help to 
identify lncRNAs that can regulate different pathways involved in this condition 
(Figure 23) and can allow the identification of novel target for more potent drugs 
contrasting skeletal muscle atrophy. 
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a)  
b)  
 
Figure 23. Principal pathways governing 
muscle stability and muscle atrophy. 
a) PGC-1α/PPARy, Growth hormones, 
mTOR, Akt are the principal pathways by 
which muscle growths; b) when FoxO1, 
NFkB, TNFα, IL-1 and IL-6 are activated, 
muscle atrophy begins and a protein 
degradation event is unrestrainable. Image 
modified from
44
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Denervation conditions were obtained as described in paragraph 3.11, cutting the 
sciatic nerve of one limb and using the other as negative control. 
Total RNA was extracted from whole muscle samples and analysed via qRT-
PCRs to investigate if pathologic conditions can affect lncRNAs expression and 
how this effect varies during the progression of muscle atrophy (Figure 24). 
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Figure 24. LncRNA expression during skeletal 
muscle denervation. 
In the heat map are reported which lncRNAs change 
their expression pattern during muscle denervation. Red 
squares indicate high expression level, instead green 
squares indicate low expression level of the genes tested 
during atrophy caused by denervation. Control: control, 
3 days DEN: RNA purified from muscle after three days 
of denervation, 7 days DEN: RNA purified from muscle 
after seven days of denervation, 14 days DEN: RNA 
purified from muscle after 14 days of denervation. Gene 
names are on the right, protein coding genes are 
identified with an asterisk (*).  
 
This analysis demonstrates that lncRNAs can be divided in different groups. All 
the analysed genes show an alteration of expression after denervation. In fact we 
evidenced that most lncRNAs are upregulated during the initial phase of 
denervation (Figure 24). This could indicate that they are involved in the initial 
process of atrophy when a huge reorganization of the muscle is commenced with 
the activation and inhibition of many genes. 
An interesting lncRNA is Mirg because it is highly expressed during denervation 
and previously showed with skeletal muscle specificity (Figure 20). Similarly, 
protein-coding gene Dio3 and lncRNA Mir143hg expression is altered after 
denervation; in this case we evidenced a diminished expression from three to 
fourteen days after denervation meaning that these genes could be targets of some 
atrophy related pathway.  
When Dio3 is active it stops growth by blocking thyroid hormones; in denervation 
Dio3 is not expressed, probably to induce growth freeing thyroid hormones from 
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Dio3. Figure 23 shows the effects of growth hormones in the activation of 
pathways controlling protein anabolism. We evidenced that Dio3 is expressed in 
fast fibers and in EDL muscles, so probably its effects on metabolism through 
thyroid hormones are more important for fast muscles; this could be due to the 
higher energy requirements of fast myofibers compared to slow myofiber. 
As previously evidenced, many genes were found to reach a peak of expression 
after three days of denervation, like for example lncRNAs Igf2os, Dio3os, Dleu2, 
Neat1, Nctc1-RI, H19 and Pvt1. LncRNAs Igf2os, Nctc1-RI and H19 are found in 
the same imprinted locus of the mouse genome suggesting a critical role for this 
locus in the control of skeletal muscle growth and pathophysiology. 
 
4.6.2 Amyotrophic Lateral Sclerosis (ALS) 
As previously described, Amyotrophic Lateral Sclerosis, is a detrimental 
disease caused by the degeneration of lower and upper motor neurons. Recently, it 
was supposed that this could be a retrograde effect that starts from the loss of 
Neuro Muscular Junction (NMJ)
45
. Loss of NMJ is also associated with aging. We 
used SOD1G93A transgenic mice a model for ALS (see paragraph 3.11) and, after 
total RNA isolation from skeletal muscle samples, we analysed the expression of 
lncRNAs and protein coding genes via qRT-PCR. We compared the expression of 
these genes in muscles extracted from one, three and four months aged mice. One 
month old mice do not manifest any muscular defect due to ALS, while at four 
months the disease is always visible. As control we used wild-type mice of the 
same age. The heat map in Figure 25 shows the expression level measured via 
qRT-PCRs in both transgenic and control mice. 
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Figure 25. LncRNAs expression in 
SOD1G93A transgenic mice. 
Heat map shows the expression of 12 
lncRNAs in ALS mice. Red squares indicate 
higher expression levels while green squares 
indicate lower expression levels. Each 
column represents a different sample; WT 1 
month: wilde-type mouse at one month of 
life (control), 93g>a 1 month: mutant mouse 
one month old (tested mouse), WT 3 
months: wilde-type mouse at three months 
of life (control), 93g>a 3 months: mutant 
mouse three months old (tested mouse), WT 
4 months: wilde-type mouse at four months 
of life (control), 93g>a 4 months: mutant 
mouse four months old (tested mouse). Gene 
names are listed on the right, protein coding 
genes are marked with an asterisk (*).  
 
We found that the great majority of lncRNAs are more expressed during the latest 
phase of the disease when the pathologic phenotype is clearly established (Figure 
25). This is in accordance with the expression of lncRNAs during denervation. 
When the muscle is wasted its expression changes radically. As seen in paragraph 
4.5.2, part of the secondary structure of Gas5 mimics the glucocorticoid response 
element, blocking it. Many pathological conditions characterized by muscle 
atrophy are often associated with increased levels of circulating glucocorticoids, 
suggesting that these hormones could play a role in muscle atrophy. 
Glucocorticoids have an effect on protein synthesis through an anti-anabolic 
action ultimately preventing the intake of amino acids into the muscle, and a 
catabolic action leading to the activation of the ubiquitin-proteasome system 
(UPS) to induce proteolysis
46
. Gas5 mimics a glucocorticoid molecule, triggering 
atrophy by promoting muscle proteins degradation. We found that Gas5 
expression increased in G93A transgenic mice compared to control mice (Figure 
25), suggesting a possible role for Gas5 in atrophy (Figures 26 and 27) and 
possibly in ALS. 
Similarly to what already observed in atrophy induced by denervation, the 
expression of genes found in the Igf2 locus is altered in ALS (Figure 25). The 
(*) 
(*) 
(*) 
(*) 
(*) 
(*) 
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opposite expression pattern of Igf2 and Igf2os already described earlier is also 
found in ALS: when Igf2 is expressed in normal conditions, Igf2os is not 
expressed. This result suggests that the presence of lncRNA Igf2os may prevent 
the expression of Igf2 transcript. Transcripts of the lncRNA/protein-coding couple 
Airn/Igf2r are down-regulated in wild-type mice and over-expressed in mutant 
mice. The correlation in the expression of these genes was found also in single 
myofibers and differentiating myoblasts. It is known that in the Igf2r imprinted 
cluster, the paternally expressed Airn lncRNA silences the paternal alleles of Igf2r 
to ensure the expression of Igf2r from the maternal chromosome. 
In this study we also evidenced an increased expression of Neat1 lncRNA at later 
stages of ALS. Neat1 is a nuclear lncRNA that forms the core structural 
component of paraspeckles and it is also a transcriptional regulator for numerous 
genes. Nishimoto et al.
28
, demonstrated that Neat1 is predominantly expressed in 
spinal motor neurons in the early phase of ALS pathological process. Neat1 
function was not completely characterised but Authors propose that Neat1 may 
act as a scaffold for RNAs and RNA binding proteins in the nuclei of ALS motor 
neurons, modulating the functions of ALS-associated RNA-binding proteins 
during the early phase of ALS. 
 
4.6.3 Starvation 
Skeletal muscle atrophy can also be induced by nutrient deprivation. 
Starvation causes decreased protein synthesis and increased protein degradation in 
both types of skeletal muscle but slow muscles, such as the soleus, are less 
sensitive to starvation compared to fast muscles. This response is likely linked to 
the difference in sensitivity between fast and slow muscles to corticosteroids.  
Similarly to what already described previously for denervation and ALS, the 
majority of lncRNAs change their expression in starved mice. 
The expression of lncRNA/protein-coding couple Airn/Igf2r is found to correlate 
during starvation, both genes are found to be increasingly upregulated at 24 and 
48 hours of starvation. 
On the contrary, the anticorrelation between Igf2os and Igf2 is not confirmed in 
starvation; conversely of what happens in denervation, we evidenced a coupled 
increase of Igf2os and Igf2 expression during at 24 and 48 hours of starvation. 
This could suggest a different role for lncRNA Igf2os during starvation rather 
than during denervation induced atrophy and/or ALS. 
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Figure 26. LncRNA expression during 
starvation in skeletal muscle. 
In the heat map is reported the expression of 
lncRNAs in skeletal muscle during 
starvation. A red square indicates high 
expression level while a green squares 
indicate low expression level of the analysed 
genes. Sources of RNA are are listed on 
each column, symbols indicate respectively: 
control RNA extracted from untreated 
muscle (C), RNA extracted after 24 hours of 
starvation (S24) and RNA extracted from 
skeletal muscle after 48 hours of starvation 
(S48) Gene names are listed on the right, 
protein coding genes are identified with an 
asterisk (*). 
(*) 
(*) 
(*) 
(*) 
(*) 
(*) 
(*) 
(*) 
(*) 
(*) 
57 
 
4.6.4 Myofiber type and skeletal muscle atrophy 
Denervation induced atrophy and ALS are known to affect more strongly fast 
myofibers rather than slow myofibers. We analysed the expression levels of the 
various myosin heavy chain isoforms to confirm that this pattern was present in 
our experiments. 
As can be seen in Figure 27 the expression of fast specific myosin isoform 
(Myh4) decreases after denervation. On the contrary, during starvation the 
expression of this gene does not change. 
The different effect on Myh4 is caused by the different processes that lead to 
atrophy in starvation rather than denervation; in starvation the neuromuscular 
junction is not impaired, while in denervation the loss of innervation causes fibers 
to lose their fast phenotype in favour of a more mixed/slow phenotype. These 
results confirm that denervation induced atrophy disrupts the expression balance 
of myosin heavy chain isoforms leading to a change in fiber type composition for 
affected muscles. 
 
 
Figure 27. Myh expression during denervation and starvation 
Histograms represent the expression of myosin heavy chain isoforms during denervation and 
starvation. Analysed samples are: RNA from muscles extracted 3, 7 and 14 days after denervation 
(D3, D7 and D14 respectively) and RNA from muscles extracted at 24 and 48 hours of starvation 
(S24 and S48 respectively). RNA extracted from an untreated muscle was used as reference 
(Control). Expression levels for each gene are relative to the expression of that gene in the 
reference sample. 
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4.7 The function of lncRNAs 
 Long non-coding RNAs (lncRNAs) are emerging as key regulators of 
diverse biological processes and diseases. They represent a heterogeneous group 
of RNAs regulating the expression at the epigenetic, transcriptional or post-
transcriptional level
47,48
. However, the function of these molecules are still poorly 
understood. LncRNAs bind specific DNA regions not only to prevent the binding 
of transcriptional activators, but also to recruit chromatin remodelling proteins to 
silence gene expression. LncRNAs can also interact with chromatin modifying 
proteins in trans to epigenetically silence genes at distant loci. LncRNA 
transcription may open the chromatin structure making it accessible to the 
transcriptional machinery and enhancing the expression of neighboring protein-
coding genes. Similarly, transcription of lncRNAs lying near or inside protein-
coding loci can repress transcription by physically preventing the transcriptional 
machinery to reach protein-coding genes. Since genes with similar expression 
patterns across multiple conditions may share similar functions
49
, or be involved 
in related biological pathways
50
, identifying protein-coding genes that are co-
expressed with lncRNAs may help to assign functions to the lncRNA counterpart. 
By analysing lncRNA-mRNA co-expression pattern, Guttman et al. identified 
several sets of mouse lncRNAs associated with protein-coding gene sets of 
distinct GO functional categories
51
. In addition, Guo et al. and Liao et al. 
independently in two recent studies, constructed a mouse co-expressed lncRNA-
mRNA network using mouse microarray data and assigned functions to 340 and 
1,625 mouse lncRNAs
52,53
. 
Here we analysed co-expressed genes of all lncRNA identified and, as particularly 
interesting examples, we report results for Pvt1 and 1110006G14Rik. As 
previously discussed (paragraph 4.5.2), Pvt1 is a well-studied lncRNA in tumors 
because of its genome location nerby to Myc and its ability to interact with the 
oncogene. It was evidenced the ability of Pvt1 to influence cell cycle, tissue 
morphogenesis and development
54
. We evidenced that genes having a correlated 
expression with Pvt1 were involved in microtubule organization, cell division, M 
phase progress and morphogenesis (Supplementary table 4). Our data support a 
Pvt1 function in cell cycle regulation also in skeletal muscle. It is an important 
aspect of skeletal muscle development and repair because both satellite cells, 
involved in muscle repair, and C2C12 cells, a model for muscle development, 
should withdraw from cell cycle to fuse into myotubes. Regarding 
1110006G14Rik, that is up regulated in fast muscles, we evidenced that its 
expression is related to genes involved in carbohydrate methabolism and in 
particular to specific muscle genes (Supplementary table 5). We evidenced that 
this lncRNA could be related to Sox6 function because of the genomic 
colocalization of those genes and a correlated expression pattern. Sox6 specify for 
fast myofibers by repressing genes of slow phenotype
42
. We evidenced that 
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1110006G14Rik expression also correlates with the expression of multiple protein 
coding genes involved in carbohydrate metabolism, which is specific of fast 
myofibers. This correlation  could be the result of either an action of 
1110006G14Rik on those genes or the regulation of 1110006G14Rik and the 
correlated genes by the same transcription factors. Moreover, the Myh4 gene, 
specific for the fast myofibers, has a correlated expression with 1110006G14Rik. 
Other genes, specific for fast myofibers exhibited a related expression with 
1110006G14Rik (Supplementary table 6). Among muscle specific genes there are 
parvalbumin, a small, stable protein containing EF-hand type calcium binding 
sites, that is localised in fast-contracting muscles
55
 and calsequestrin 1 also 
prevalently expressed in EDL
56
 indicating that calcium regulation is important in 
muscle fibre specification
55
. 
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Chapter 5 – Conclusions 
 
Whole genome technologies allow the identification of non-coding RNAs as 
important regulators of gene expression. Long non-coding RNAs can participate 
in the regulation of different cellular processes such as stem cell pluripotency, 
immune response, neural processes, and cell cycle regulation. 
We investigated the role of lncRNAs in skeletal muscle using a genome wide 
approach to describe their subcellular localization and specific gene expression to 
describe their tissue specificity, fiber type specificity and involvement in C2C12 
differentiation. We found that most analysed lncRNAs are expressed specifically 
in striated muscles and that many showed a fiber specific expression. 
Genome wide approach allowed the identification of 655 cytoplasmic and 481 
nuclear lncRNAs, confirming the unexpected abundance of cytoplasmic lncRNAs 
already described by van Heesch, S. et al
36
 in human colon cancer cells. 
Moreover, we evidenced that most of them are expressed in the same subcellular 
compartment in myofibers derived from Soleus, EDL and Tibialis Anterior with a 
small number of lncRNAs that are instead specific for each muscle. 
Genome-wide lncRNA subcellular localization was then confirmed using 
Fluorescence In Situ Hybridization (FISH) to target specific lncRNAs. Notably, 
Gt(ROSA)26Sor, Neat1, Mir143hg and Nctc1-RI evidenced nuclear localization in 
skeletal muscle while H19 and Airn were found in both compartments, as 
predicted from microarray analysis. This result can sustain the validity of our 
approach to dissect lncRNA subcellular localization in a genome wide fashion. 
QRT-PCR test not only showed that most of the target lncRNAs were specifically 
expressed in striated muscle, but also identify which lncRNA are specifically 
expressed in extensor digitorum longus (fast glycolytic muscle) and in soleus 
(slow oxidative muscle). 
To further confirm lncRNA relation with muscle metabolism we analyzed RNA 
extracted from both fast and slow single myofibers. In fact, RNA extracted from 
whole muscle is a mixture of RNA from conctractile cells and from epithelial, 
neuronal, blood cells present in the muscle. The analysis of single myofibers 
showed that 1110020A21Rik, Dancr, and Gas5 are over expressed in slow 
myofibers, while 1110006G14Rik, 2310065F04Rik, Gm16062, Pvt1, and Snhg6 
are over expressed in fast myofibers. We also identified three protein-coding 
genes specifically expressed in fast myofibers (Dio3, Cops3 and Sox6) and one in 
slow myofibers (Myh3). 
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The identification that Sox6 is specific for fast fibers and EDL can be considered 
as a validating data since it is known to be enriched in fast myofiber. It, in fact, 
exert its action repressing slow muscle gene
41
. 
Interestingly, lncRNAs lying in a common genomic position with coding RNAs 
have, in some cases, a correlated expression that could result from a functional 
relationship or from the sharing of a common regulatory expression pattern. An 
example of this behavior is the lncRNA/protein-coding couple 
1110006G14Rik/Sox6; in this case the lncRNA is located within an intron of the 
protein-coding gene, and the two transcripts show the same expression profile 
both in tissues and single myofibers. Since Sox6 is involved in muscle fiber 
specification, it could be very interesting to analyze the involvement of this 
lncRNA in the same process. There is little evidence of lncRNA involvement in 
fiber specification and therefore in metabolism regulation. We correlated the 
expression of whole coding expression genes with 1110006G14Rik evidencing 
that correlated genes are involved in carbohydrate metabolism, that is specific for 
fast myofibers, and peculiar fast muscle specific genes. These results could 
sustain the involvement of this lncRNA in fiber specification. 
We then used qRT-PCR to measure lncRNA expression and subcellular 
localization in differentiating myoblasts. 
Several lncRNA analysed in cell cultures were found to have the same 
localization previously identified in skeletal muscle myofibers. This supports the 
use of C2C12 cells to study the function of lncRNA in-vitro altering their 
expression, supposing that the observed effects compare the function of lncRNA 
in-vivo. 
Notably, lncRNA Pvt1 that is known to be involved in cell cycle regulation, was 
found to switch its localization from cytoplasmic to nuclear after the induction of 
myoblast differentiation, leading us to believe that it could possibly have a role in 
muscle development and/or regeneration. Pvt1 could function as miRNA sponge 
or miRNA precursor when localized in the cytoplasm and as chromatin regulator 
when localized in nuclei. A correlation analysis with coding genes demonstrated 
that Pvt1 correlates with genes involved in cell cycle regulation supporting the 
idea that it could regulate cell cycle during differentiation. In fact, it is important 
that cells withdraw from cell cycle to allow cell fusion and the formation of 
myotubes. 
Since evidences of lncRNA involvement in different diseases are already clear, 
we decided to monitor their expressions during atrophy. We chose three different 
models of atrophy: denervation and starvation induced atrophy plus the most 
commonly used transgenic mouse model for ALS. 
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Most lncRNAs resulted activated in all atrophy models with Pvt1 showing an 
early activation during denervation. Moreover, Myh4 expression which is typical 
of fast myofibers was found to decrease during denervation, confirming the 
stronger effect of denervation on fast myofibers. 
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Supplementary materials 
 
Supplementary Table 1. Primers for qRT-PCR and construction of FISH probes 
Gene name Primers qRT-PCR FISH 
Airn 
F CTCCAGAAACTAGACACTACAGACCA GCTCCAATTTCCCATGTCTC 
R TGTAAAGTCTTCAAGGATCTAGGGC TGCCTCTTTCCCACTTCTGT 
Cd46 
F CCCTATTTCAGATGCTGGTTG - 
R TGCCAAATGAAGGGTCTTGT - 
Cd46 
F TGCATTAGAAAGCAGCAGTAGC - 
R ATTCCTTCACGGGGACTAGG - 
Cops3 
F ATTCAACCAACAACCCGTCT - 
R AGTGAAGGTCTCGCTGTGCT - 
Dancr 
F CCCTTCTTCATGTCCCACTG TGACTGAATGGCTCCAAGG 
R AAACGGCGAGCATGTCATAG AGAATTGACACAGGAAGCCTTTA 
Dio3 
F CATCCGCAAGCATTTCC CAAATGCTCCAAAGAAAGTCAA 
R GCATCTCCTCGCCTTCAC CGAAGTCCATCCCTTACCA 
Dio3os 
F TCCTTCTGGTCCTGCTCTATG CTGGGGGCAAGGGAGTAA 
R TTTCCCAAGTGTCCCATATCA ATCCTGAGGTGTGGGGTGTA 
Dleu2 
F GATGTTGGGGCGGAGAG - 
R TCAGCGACGGAGGAAGAC - 
Dlx6 
F CTTAGGACTGACACAAACACAGGT CACCATCACCACCACCAG 
R GGTCACTCTCGTGTGGGTTACTAC AGGCAGAAACGTCCCACA 
Dlx6os 
F GCCCTCTGCTTCACTTCC GCCCTCTGCTTCACTTCCA 
R GACCTGGCTCCCTCTCTCT CCCGCTCACTTCCTCCA 
Dnm3 
F CCAAACCAGAAACCCTACCA CGAAGTCAGCAACACAATGAA 
R CGGGGAGAGAAGAGGAATACA CTTGAGCAGTGGAATGAGGA 
Dnm3os 
F GGCACACTTGAGATTTTATCCTTC ACACCTTTGCTGCCTCCT 
R CGACTACTACTGTTTGTTGTTTCCA CCCTGACCACTTCTCCAGTT 
Gas5 
F CTGGCTTGCTTGGGTAAGA - 
R GCATGTTCAAAAGCTAAATGTTATG - 
Gm6781 
F GGAGGTGTGGGGCAGATAC - 
R GCTGTAGGGCGTTGGTTATG - 
Gm11190 
F CCCTTCCTCATTTCCTCCAG - 
R ATCTGCTCCCGATTCACTCC - 
Gm11766 
F CTGAACTCGGGCTATGGTCA - 
R GTTGGAAGGGGACAGGAGAG - 
Gm11767 
F GGTGTTTTTCCTGCCTTCCT - 
R TCCTGCCTAAGTGTCTGAGCA - 
Gm12260 
F GAGATCGCCCAGGACTTCA - 
R GCACAGGTTCGTGTCTTCG - 
Gm16062 
F CCCTGTCCCTACCGAAGAG - 
R GTCCCAAGAACTCCCAGAATC - 
Gt(ROSA)26or 
F TTTGTATGTGAGGATAAAGGTGTTTG CAGGACAGTGCTTGTTTAAGG 
R TTTGGAACTTTGGGGAAATGT CTCGCACCAACACAAAAGT 
H19 
F GAGACCACCACCCACATCAT CCTCCCCCTACCTTGAACC 
R GGAGGAAGAAGAAAAAGACAGGA CAGACGGAGATGGACGACA 
Igf2 
F CGGTGTGTGTCAGCCAAG AGGTGGAAGAATCAGGAGGA 
R TGAGTTTCTGTCCAATGTTCCA CCCCAAATGCTCAGAAGG 
(continues inthe next page) 
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Gene name Primers qRT-PCR FISH 
Igf2os 
F GCTGGAAGGGGCTGAGTC TCCCAGTTGTCCTTTTGTCC 
R CAGTGGTGGAGAGCAGAAGC ACCCTCTAATGCCCCCATAC 
Igf2r 
F GTTGGTGTAGGGCCAGTGTT AAACCCTTGCTGCTTTAGTCC 
R AAATTCTGCGGGGTACTTTG TTTCTCTGACACCTCAACTCCA 
Mir22hg 
F ATGGCTCTGCTGTCCTCATC CGCTGGGAAGAGACAGAG 
R GGTCCTCCACTGTCTTGTGC ACCTACCAACTGAGCTACAACC 
Mir143hg 
F CAGTCACCACGAAGCAAAGG AAGCAATAACACCCACAACC 
R ACCCCCAAACCACCTACTCA TAGAACCTGCCGATGACTTT 
Mirg 
F CCACCCCAGAGCCTTGTATT - 
R AAGAGCAGAAACCCCTCCTTC - 
Myh3 
F CGCCTGAAGAAGAAGATGG - 
R CGGAGGTGCTTGATGGT - 
Neat1 
F CATTGTGGGTTTGGCTTGA TCCAATGCTGCTATCTAAAGG 
R GACAGTTTAACAGCTTCCCCTCT GTAAAGGGGAGGAAAATGGT 
Nctc1 -lnc 
F TGAGAAGGAAGCAGTGACAAGTA CAACCACCACACCAGGACTA 
R AAGGCAGAGTTGGGCTATCC GGCATTGGAGAGGAGCATAGA 
Nctc1- RI 
F CAGCCCAGAGTTTTGTAAGCC CTTTGAGGGTCTGGGAAGGT 
R CAAATAACACCTGGAGAGGAAGG TGCCTGGTGTGTGTTCTCTC 
Ppm1b 
F AGGGTTAGAGATTACTGGTTGGA - 
R GGTATGAGGATGGAAAATAAGCA - 
Pvt1 
F CTTGTATGGGTGGTGGCTTT CTTAGTGAATGCTGGCTTGTG 
R CCAGGGAGAGAGTGGTGTG TGGCTACTGAAAGAAGGAAGGT 
Snhg1 
F AGGGATCATTTTTGTGCGTAGA AGAACAAAGGAGCCGTACCA 
R GCTCATTCTTTTCCTCAGACCTG TTGCTAGAACAAACACAGAGTACAAG 
Snhg6 
F ATGTAGGTGGCTGTAGTGGATG - 
R CAATAAAGGGTTTTTAGACATCACAG - 
Snhg7 
F GATTGGCTTGGGTTTGACTCT TGGCGGCTCTATGTTTGTATC 
R GGGTCCTCCATCCAGTGTTT CCAGTTATCACCACCCAACTC 
Sox6 
F CTTTGTCCCCATCCTGACC - 
R CTTTTCCATCCCTCCCAGAA - 
A330023F24Rik 
F TTGATGAGTGATGTTGAGGTTTG ATCCTTGCTGGTTCCTTCC 
R TTAGCCCAAGGGTGAGGAG AAATAACATCTGCCACACATCC 
1110006G14Rik 
F TCGGTTTGTGTACTGCTGAGA - 
R GGGACTCCAGGATCTTCGTA - 
1110020A21Rik 
F GGTAGAGTCCTCCGTCAGTCA - 
R GCCATTTGAACCAATCAGAAA - 
2310065F04Rik 
F GTGAGCGTGAGATGTTCGTG ACCCCTCTCCCCTATTCTCC 
R AAAGTGCATCCCCTCTGCTT CACGAACATCTCACGCTCAC 
4930509E16Rik 
F AGGACAACTGAAGAGACTACCCAAT - 
R TCTGACAAGACTGAAAACAACAAGA - 
9530059O14Rik 
F CCCATTCAAAATCAATACACTTACA CCTGACTTGTATATTCTGATTCCTTG 
R TTCTTCTCCTCCACCACACC TGTTCCTAGTCCAGTTCTTTGTTG 
B2m 
F CCGTCTACTGGGATCGACAC - 
R GCTATTTCTTTCTGCGTGCAT - 
Tbp 
F TGCTGTTGGTGATTGTTGGT - 
R AACTGGCTTGTGTGGGAAAG - 
Tnx1 
F TCCAATGTGGTGTTCCTTGA - 
R GGCTTCAAGCTTTTCCTTGTT - 
  
73 
 
Supplementary Table 2. Restriction Enzymes 
 
  Enzyme Conc.[U/ml] Sequence Cut site Overhang 
Neat1 
control HindIII 20U/ml AAGCTT 
A/AGCTT 
TTCGA/A 
5′ - AGCT 
probe Xba1 20U/ml TCTAGA 
T/CTAGA 
AGATC/T 
5′ - CTAG 
Igf2os 
control HindIII 20U/ml AAGCTT 
A/AGCTT 
TTCGA/A 
5′ - AGCT 
probe Xba1 20U/ml TCTAGA 
T/CTAGA 
AGATC/T 
5′ - CTAG 
Airn 
control Xba1 20U/ml TCTAGA 
T/CTAGA 
AGATC/T 
5′ - CTAG 
probe HindIII 20U/ml AAGCTT 
A/AGCTT 
TTCGA/A 
5′ - AGCT 
H19 
control Xba1 20U/ml TCTAGA 
T/CTAGA 
AGATC/T 
5′ - CTAG 
probe HindIII 20U/ml AAGCTT 
A/AGCTT 
TTCGA/A 
5′ - AGCT 
Mir143hg 
control Xba1 20U/ml TCTAGA 
T/CTAGA 
AGATC/T 
5′ - CTAG 
probe HindIII 20U/ml AAGCTT 
A/AGCTT 
TTCGA/A 
5′ - AGCT 
Gt(ROSA)26Sor 
control HindIII 20U/ml AAGCTT 
A/AGCTT 
TTCGA/A 
5′ - AGCT 
probe Xba1 20U/ml TCTAGA 
T/CTAGA 
AGATC/T 
5′ - CTAG 
Nctc1-RI 
control Xba1 20U/ml TCTAGA 
T/CTAGA 
AGATC/T 
5′ - CTAG 
probe Spe1 10U/ml ACTAGT 
A/CTAGT 
TGATC/A 
5′ - CTAG 
Mir22hg 
control Spe1 10U/ml ACTAGT 
A/CTAGT 
TGATC/A 
5′ - CTAG 
probe Xba1 20U/ml TCTAGA 
T/CTAGA 
AGATC/T 
5′ - CTAG 
Pvt1 
control Noti 10U/ml GCGGCCGC  
GC/GGCCGC 
CGCCGG/CG 
5′- GGCC 
probe HindIII 20U/ml AAGCTT 
A/AGCTT 
TTCGA/A 
5′ - AGCT 
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Supplementary Figure 1. Histogram of slow specific lncRNAs.  
 
Supplementary Figure 2. Histogram of fast specific lncRNAs.  
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Supplementary Figure 3. Histogram of fast protein-coding genes.  
 
 
 
Supplementary Figure 4. Genes having correlated expression with Pvt1 (pvalue < 0.05) 
Annotation Cluster Enrichment Score: 0.9785600266815854 
Term Genes 
GO:0005856 
cytoskeleton 
SS18, FMN2, FERMT2, GM5593, KIF19A, TGM3, MYO19, 
TTLL7, CDC27, GABARAP, ARHGAP26, SNTA1 
GO:0015630 
microtubule 
cytoskeleton 
SS18, GM5593, KIF19A, TTLL7, CDC27, GABARAP 
GO:0007017 
microtubule-based 
process 
SS18, FMN2, KIF19A, GABARAP 
GO:0005874 
microtubule 
SS18, KIF19A, CDC27, GABARAP 
GO:0044430 
cytoskeletal part 
SS18, FERMT2, GM5593, KIF19A, MYO19, TTLL7, CDC27, 
GABARAP 
GO:0005815 
microtubule organizing 
center 
GM5593, TTLL7, CDC27 
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Annotation Cluster Enrichment Score: 0.7676543517241499 
Term Genes 
GO:0001763 
morphogenesis of a 
branching structure 
FGFR1, GCM1, CD44, PHB2 
GO:0022612 
gland morphogenesis 
FGFR1, CD44, PHB2 
    
Annotation Cluster Enrichment Score: 0.6069845696013708 
Term Genes 
GO:0007017 
microtubule-based 
process 
SS18, FMN2, KIF19A, GABARAP 
GO:0000226 
microtubule 
cytoskeleton 
organization 
SS18, FMN2, GABARAP 
GO:0007010 
cytoskeleton 
organization 
SS18, FMN2, GABARAP 
    
Annotation Cluster Enrichment Score: 0.5412778122684933 
Term Genes 
GO:0051301 
cell division 
FMN2, DSN1, GM5593, PELO, CDC27 
cell division DSN1, GM5593, PELO, CDC27 
GO:0007049 
cell cycle 
FMN2, GM13337, DSN1, GM5593, PELO, GM3852, CDC27 
GO:0022402 
cell cycle process 
FMN2, GM13337, DSN1, GM5593, CDC27 
GO:0000279 
M phase 
FMN2, DSN1, GM5593, CDC27 
GO:0000280 
nuclear division 
DSN1, GM5593, CDC27 
GO:0007067 
mitosis 
DSN1, GM5593, CDC27 
GO:0022403 
cell cycle phase 
FMN2, DSN1, GM5593, CDC27 
GO:0000087 
M phase of mitotic cell 
cycle 
DSN1, GM5593, CDC27 
GO:0048285 
organelle fission 
DSN1, GM5593, CDC27 
GO:0000278 
mitotic cell cycle 
DSN1, GM5593, CDC27 
cell cycle DSN1, GM5593, PELO, GM3852 
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Supplementary Figure 6. Genes that correlate with 1110006G14Rik (pvalue < 0.05) 
Annotation Cluster Enrichment Score: 6.146094352993051 
Term Genes 
GO:0006006 
glucose metabolic 
process 
ALDOA, GM14148, LDHA, GM4217, GM5787, GM2308, 
PHKA1, GM15191, GPI1, GM8318, TPI1, GM7784, ENO3, 
GM3839, GM8174, GM9034, AGL, GM7251, GPD1, 
GM7611, GM10313, GM6498, PGM2, GM5732, GM9568, 
GM11953, GM3809, GM7286, GM9061 
glycolysis 
ALDOA, GM14148, LDHA, GM7611, GM10313, GM4217, 
GM5787, GM2308, GM15191, GM6498, GPI1, GM8318, 
GM5732, GM7784, TPI1, GM11953, GM8174, GM9568, 
GM3839, ENO3, GM3809, GM7286, GM9034, GM9061 
GO:0044275 
cellular carbohydrate 
catabolic process 
ALDOA, GM14148, LDHA, GM4217, GM5787, GM2308, 
GM15191, GPI1, GM8318, TPI1, GM7784, ENO3, GM3839, 
GM8174, GM9034, GPD1, GM7611, GM10313, GM6498, 
GM5732, GM9568, GM11953, GM3809, GM7286, 
GM9061 
GO:0006096 
glycolysis 
ALDOA, GM14148, LDHA, GM7611, GM10313, GM4217, 
GM5787, GM2308, GM15191, GM6498, GPI1, GM8318, 
GM5732, GM7784, TPI1, GM11953, GM8174, GM9568, 
GM3839, ENO3, GM3809, GM7286, GM9034, GM9061 
GO:0016052 
carbohydrate catabolic 
process 
ALDOA, GM14148, LDHA, GM4217, GM5787, GM2308, 
GM15191, GPI1, GM8318, TPI1, GM7784, ENO3, GM3839, 
GM8174, GM9034, GPD1, GM7611, GM10313, GM6498, 
GM5732, GM9568, GM11953, GM3809, GM7286, 
GM9061 
  
Annotation Cluster Enrichment Score: 3.587680656719181 
Term Genes 
GO:0044275 
cellular carbohydrate 
catabolic process 
ALDOA, GM14148, LDHA, GM4217, GM5787, GM2308, 
GM15191, GPI1, GM8318, TPI1, GM7784, ENO3, GM3839, 
GM8174, GM9034, GPD1, GM7611, GM10313, GM6498, 
GM5732, GM9568, GM11953, GM3809, GM7286, 
GM9061 
GO:0016052 
carbohydrate catabolic 
process 
ALDOA, GM14148, LDHA, GM4217, GM5787, GM2308, 
GM15191, GPI1, GM8318, TPI1, GM7784, ENO3, GM3839, 
GM8174, GM9034, GPD1, GM7611, GM10313, GM6498, 
GM5732, GM9568, GM11953, GM3809, GM7286, 
GM9061 
GO:0034637 
cellular carbohydrate 
biosynthetic process 
GPD1, TPI1, GPI1, AGL 
GO:0016051 
carbohydrate 
biosynthetic process 
GPD1, TPI1, GPI1, AGL 
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Annotation Cluster Enrichment Score: 2.0873684198886866 
Term Genes 
muscle protein 
ACTC1, MYBPC2, MYH1, PVALB, PHKA1, MYH4, CASQ1, 
TPM1, MYH8, TNNI2 
GO:0006936 
muscle contraction 
MYBPC2, MYOM2, MYH1, MYH4, TPM1, MYH8 
thick filament MYBPC2, MYH1, MYH4, MYH8 
GO:0003012 
muscle system process 
MYBPC2, MYOM2, MYH1, MYH4, TPM1, MYH8 
GO:0032982 
myosin filament 
MYBPC2, MYH1, MYH4, MYH8 
GO:0006941 
striated muscle 
contraction 
MYH1, MYH4, TPM1, MYH8 
GO:0005200 
structural constituent 
of cytoskeleton 
MYBPC2, MYOM2, GM5620, TPM1 
IPR015650:Heavy chain 
of Myosin 
MYH1, MYH4, MYH8 
GO:0005863 
striated muscle thick 
filament 
MYH1, MYH4, MYH8 
GO:0030017 
sarcomere 
ACTC1, MYH1, MYH4, TPM1, MYH8 
GO:0044449 
contractile fiber part 
ACTC1, MYH1, MYH4, TPM1, MYH8 
IPR004009:Myosin, N-
terminal, SH3-like 
MYH1, MYH4, MYH8 
GO:0005859 
muscle myosin complex 
MYH1, MYH4, MYH8 
GO:0030016 
myofibril 
ACTC1, MYH1, MYH4, TPM1, MYH8 
IPR002928:Myosin tail MYH1, MYH4, MYH8 
GO:0043292 
contractile fiber 
ACTC1, MYH1, MYH4, TPM1, MYH8 
GO:0016460 
myosin II complex 
MYH1, MYH4, MYH8 
actin-binding MYBPC2, MYH1, MYH4, TPM1, MYH8, TNNI2 
GO:0016459 
myosin complex 
MYBPC2, MYH1, MYH4, MYH8 
GO:0015629 
actin cytoskeleton 
MYBPC2, MYH1, MYH4, MYOZ1, TPM1, MYH8 
region of interest:Actin-
binding 
MYH1, MYH4, MYH8 
domain:Myosin head-
like 
MYH1, MYH4, MYH8 
IPR001609:Myosin 
head, motor region 
MYH1, MYH4, MYH8 
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Term Genes 
GO:0003779 
actin binding 
MYBPC2, MYH1, MYH4, TPM1, MYH8, TNNI2 
myosin MYH1, MYH4, MYH8 
GO:0051015 
actin filament binding 
MYH1, MYH4, MYH8 
GO:0008092 
cytoskeletal protein 
binding 
MYBPC2, MYH1, MYH4, TPM1, MYH8, TNNI2 
motor protein MYH1, MYH4, MYH8 
mmu04530:Tight 
junction 
GNAI2, MYH1, MYH4, MYH8 
GO:0003774 
motor activity 
MYH1, MYH4, MYH8 
GO:0005856 
cytoskeleton 
ACTC1, MYBPC2, MYOM2, MYH1, GM5620, MYH4, 
MYOZ1, TPM1, MYH8 
GO:0044430 
cytoskeletal part 
MYBPC2, MYH1, GM5620, MYH4, TPM1, MYH8 
 
Supplementary Figure 6. Genes that correlate with 1110006G14Rik 
ID Gene Name Species 
Actc1 
actin, alpha, cardiac muscle 1; similar 
to alpha-actin (AA 27-375) 
Mus musculus 
Casq1 calsequestrin 1 Mus musculus 
Mybpc2 myosin binding protein C, fast-type Mus musculus 
Myh1 
myosin, heavy polypeptide 2, skeletal 
muscle, adult; myosin, heavy 
polypeptide 1, skeletal muscle, adult 
Mus musculus 
Myh4 
myosin, heavy polypeptide 4, skeletal 
muscle 
Mus musculus 
Myh8 
myosin, heavy polypeptide 8, skeletal 
muscle, perinatal 
Mus musculus 
Pvalb parvalbumin Mus musculus 
Phka1 phosphorylase kinase alpha 1 Mus musculus 
Tpm1 tropomyosin 1, alpha Mus musculus 
Tnni2 troponin I, skeletal, fast 2 Mus musculus 
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